Lord Scriven debates involving the Department of Health and Social Care during the 2024 Parliament

Tue 17th Nov 2026
Health Bill
Lords Chamber

Committee stage: Part 2
Wed 11th Nov 2026
Health Bill
Lords Chamber

Committee stage: Part 2
Wed 11th Nov 2026
Health Bill
Lords Chamber

Committee stage: Part 1
Mon 9th Nov 2026
Health Bill
Lords Chamber

Committee stage
Tue 3rd Nov 2026
Health Bill
Lords Chamber

Committee stage part one
Tue 3rd Nov 2026
Health Bill
Lords Chamber

Committee stage part two
Wed 28th Oct 2026
Health Bill
Lords Chamber

Committee stage (part one)
I hope we can all agree with that.
Lord Scriven Portrait Lord Scriven (LD)
- View Speech - Hansard - -

My Lords, this has been an important debate on a subject that too often generates more heat than light. I thank noble Lords who have spoken for the tone in which the debate has been held. In particular, I thank the noble Baroness, Lady Cass, whose review has done more than anything else to move the debate from slogans to trying to get us to follow the evidence.

We should start with where the law stands today on puberty blockers, because it matters. The sale and supply of in-person puberty blockers to under-18s for gender dysphoria outside a clinical trial has been banned indefinitely since the start of 2025 and the PATHWAYS trial has now been approved by the regulator. In March this year, NHS England paused new prescriptions of cross-sex hormones for under-18s. In February, the Government laid an order under the Gender Recognition Act so that the data linkage study can lawfully go ahead. A great deal has changed, but this Bill will abolish NHS England and almost every one of those commitments lives in NHS England’s policy documents, not in law. The question for the Committee is simple: when that body goes, who will hold the pen and who will answer to Parliament? I would welcome the Minister’s answer to that.

These Benches—as I am sure all Benches do— approach this from three principles: the evidence should lead; every person who walks into a clinic, whether they are seeking to transition, to explore or to detransition, deserves dignity and proper care; and people’s privacy must be protected. I do not believe that those principles are in conflict, as the review of the noble Baroness, Lady Cass, showed. They all belong together.

On Amendment 75, the Levy review found that waits for a first appointment were heading towards 15 years and that clinics could not say whether the treatment they gave had worked, because outcomes were not systematically recorded. A national specification, national commissioning, outcome data and a single waiting list are not an attack on anybody; they are what you would expect of any other specialised service. As the noble Lord, Lord Hunt, said, this is probably not the responsibility of an ICB. Can the Minister tell us who will be accountable for each of Dr Levy’s 20 recommendations once NHS England has gone? On the list of specialised commissioning, do the Government expect this to be a national commissioning service or a local ICB commissioning service?

I turn to Amendment 275 on the data duty. The noble Baroness, Lady Davies, raised some important points, but, as my noble friend Lady Barker said, we have to consider the context of what is happening in looking at a data duty. Six of the seven adult clinics did not give data to the Cass review. This is not acceptable for any public body or any publicly funded service. It has left us with a bit of a gap for young people in terms of what happened to those who went before them. A legal duty may be justified, but, because this is some of the most sensitive data that the NHS holds, the safeguards matter—ethical approval, pseudonymisation and use for that study only. Can the Minister say whether the February order does the job for the Cass study? If so, will such orders extend that same protection to other approved studies? There is an issue, as my noble friend Lady Barker said, about the time limit on collecting such data.

On Amendment 276, people who detransition have often been invisible—unwelcome in some gender services and unknown to everybody else. They deserve care without judgment. The Government have told this House that consultation on a service specification will not come until autumn 2027. A statutory deadline and anonymised annual reporting would help us learn. Learning is not blaming, and that is the point. Is that timeline still applicable?

In relation to Amendment 279QP, I sit on the Draft Conversion Practices Bill Joint Committee. I will not prejudge its work, but it is grappling with and well aware of some of the issues that noble Lords are talking about. Clinicians must be confident that they can treat a young person’s autism, anxiety or trauma and explore their distress without presuming an outcome and without fear that this will be called a conversion practice or that they will be held to a criminal charge. Equally, genuinely coercive practices must be outlawed, and proposed new subsection (5) in the amendment recognises that. Getting that line right matters to everybody, and I would welcome the Minister’s views on how this amendment fits with the draft Bill. Does she feel that it would be useful or not in terms of the issues that noble Lords have raised?

Finally, I turn to Amendment 279QQ. There seems to be an inconsistency in the current position. If the evidence is strong enough for the NHS not to start a 16 year-old on these hormones, how do the Government explain that the same young person can obtain them from a private or overseas prescriber online, outside of any specialist assessment? Closing that gap may be a safeguarding issue, so I would welcome the Minister’s view.

The review of the noble Baroness, Lady Cass, asked us to remember that these are children, young people and adults who deserve the same standard of evidence-based care as everyone else. That is not a position on either side of a deeply divided or polarised argument; it is simply good medicine. I look forward to the Minister’s reply.

Baroness Cash Portrait Baroness Cash (Con)
- Hansard - - - Excerpts

My Lords, I am grateful to all noble Lords who have spoken in this important group. I am particularly grateful to my noble friend Lady Davies and the noble Baroness, Lady Cass, for tabling their amendments. It is pleasing, to say the least, to see consensus emerging in this area, because we are talking about some of the most vulnerable young people likely to encounter healthcare.

The amendments in this group share some objectives: the treatment of children and young adults for gender distress needs to rest on evidence, as the noble Baroness, Lady Barker, rightly pointed out; and we must be absolutely clear on who is accountable for the services provided to them. I support my noble friend’s Amendments 75, 275 and 276, which really amount to questions about accountability. I am grateful to the noble Lord, Lord Scriven, for saving me from making some of the same points and asking some of the same questions of the Minister. I largely agree with what he posed in respect of accountability around the standards of care to be applied. I am also grateful for the expertise of the noble Baroness, Lady Cass, and the noble Lord, Lord Singh, to whom I defer as practitioners with expertise in the care of children, and in mental health and therapeutic care in the case of the noble Lord.

Evidence is being heard by the Select Committee at the moment in pre-legislative scrutiny, but it is an enormous worry that, listening to the medical expertise today, it is unclear to practitioners that they will be safe to carry out what everyone who has spoken today agrees on regarding the safety of care of these young people. It needs to be possible, as the noble Lord, Lord Scriven, said, to explore autism, anxiety or any of the other comorbidities we know about. We also know that a very high proportion of cared-for children present with gender dysphoria. I noted that, with her typical wisdom, the noble Baroness, Lady Cass, distinguished between sexual orientation and gender dysphoria because of the significance of desisting and detransitioning which takes place around gender dysphoria. It is far from clear in many of these young people. In fact, there is data to suggest that the majority of them desist and grow up to be young gay people.

I am pleased that we have finally achieved some consensus in all this and understood that, together, our priority is the right care and standards for these young people. It is in that spirit that I have tabled Amendment 279QQ on the prescribing of masculinising and feminising hormones—I will say, “cross-sex hormones”, if noble Lords do not mind, because that is quite a mouthful, although I appreciate the correct terminology—for children under 18.

The Government deserve credit for the steps they have already taken regarding puberty blockers, a ban they made permanent in 2025. They also stopped the starting of new prescriptions for cross-sex hormones, as the noble Lord, Lord Scriven, pointed out, under the then Health Secretary, Wes Streeting, who explained in full to Parliament why he had done that, with the evidence reviews finding very limited and weak evidence to support their use. GPs have been advised not to enter shared care with unregulated providers. All those steps taken by this Government were right, and I support them.

--- Later in debate ---
Baroness Cass Portrait Baroness Cass (CB)
- View Speech - Hansard - - - Excerpts

My Lords, my Amendment 94A seeks to require every integrated care board to appoint an executive lead for children and young people aged from nought to 25. We made the case for this very strongly in the group on children earlier. Although this is a statutory role currently under NHS England, the NSPCC did an audit and found that implementation was very patchy. Large numbers of ICBs did not have such a lead or, if they did, they had this role as part of a very wide range of other duties and there was variable expertise and backgrounds in those undertaking it. With the reducing numbers in ICBs, there is a significant risk of children and young people getting lost. That is why I propose that this should go into the Bill.

Lord Scriven Portrait Lord Scriven (LD)
- View Speech - Hansard - -

My Lords, every noble Lord who has spoken has raised an important point about who should sit on an ICB board so that that board can come to an opinion about what is best for that local area’s health outcomes. However, I remind noble Lords that Clause 11 gives quite interesting powers to the Secretary of State. There are two new powers. First, NHS England in its present form cannot direct an ICB if it is performing well; under this Bill, we could have the best people with all the knowledge, but the Secretary of State can completely ignore anybody who is on the ICB and direct that it carries something out even if that ICB is working well. Secondly, and importantly, noble Lords are asking for these members to sit on ICBs so that the ICB can form an opinion on what is correct in its area. The other new power in Clause 11 is that the Secretary of State can direct an ICB regardless of whether it has come to an opinion at all. It is the Secretary of State’s opinion that matters. I say to the Minister that these amendments would be irrelevant because the real power over what an ICB does and who ultimately decides is with the Secretary of State.

Lord Bradley Portrait Lord Bradley (Lab)
- View Speech - Hansard - - - Excerpts

My Lords, I strongly support the amendment on allied health professionals tabled by the noble Baroness, Lady Finlay. I will ignore the fact that the amendments may be irrelevant and carry on with my speech. Allied health professionals make up the third-largest section of the health workforce and have a crucial role to play in the delivery of services. Speech and language therapists—I declare an interest as the honorary vice-president of the Royal College of Speech and Language Therapists—are one of the 14 allied health professionals. They support people of all ages—babies, children, young people and adults—who have communication disability, difficulty and differences, which are particularly relevant to eating, drinking and swallowing. They also support family members and carers of people with communication and swallowing needs, and the wider workforce supporting those people, through advice and training. Allied health professionals, including speech and language therapists, work across a range of settings such as education, health, justice and social care.

It is in that context that I fully support Amendment 81A from the noble Baroness, Lady Finlay, because it is critical that the expertise of the wider allied health professional clinical workforce is reflected in strategic decision-making, service planning, commissioning and the development of integrated neighbourhood health services. AHPs are a vital part of the NHS community workforce and provide essential expertise across the full patient pathway, from prevention and early intervention through to diagnosis, treatment, rehabilitation and ongoing management of long-term conditions. Their contribution extends beyond individual clinical intervention to population health, reducing health inequalities, supporting independent living and preventing avoidable hospital admissions.

Without formal AHP representation, there is a risk that ICB decision-making will not adequately reflect the breadth of clinical expertise required to plan and deliver integrated multidisciplinary and preventive services. The amendment would therefore ensure that allied health professionals have a meaningful voice at ICB level, rather than relying solely on ad hoc consultation or representation through other professional groups. Without an AHP voice on ICBs, there is a risk that the AHP workforce needed for neighbourhood health and rehabilitation will not be properly planned for. If the amendment is rejected, how do the Government intend to ensure that allied health professionals and their experience and expertise are represented within ICB governance arrangements?

On Amendment 81, I would be grateful if my noble friend the Minister could clarify the accountability of ICB chairs. I understand that there is a proposal that the mayor will appoint a health service commissioner as a deputy mayor, and this person could also be the chair of the ICB. This is further suggested in the Milburn review published today for the development of a youth opportunity service. In terms of public accountability and transparency, will the ICB chair be accountable to the Secretary of State for Health and Social Care, or to the Secretary of State for Housing, Communities and Local Government through the mayor’s office, or to both, or will another member of the Government take ultimate responsibility? I am sure the Minister has a simple answer for me.

--- Later in debate ---
Lord Scriven Portrait Lord Scriven (LD)
- Hansard - -

My Lords—

Lord Hunt of Kings Heath Portrait Lord Hunt of Kings Heath (Lab)
- Hansard - - - Excerpts

I will give way if the noble Lord can help me.

Lord Scriven Portrait Lord Scriven (LD)
- Hansard - -

It is in South Yorkshire that the first health commissioner has been appointed, and the press release—although you cannot believe everything in a departmental press release—says that the commissioner will be jointly accountable to the mayor and to the Secretary of State for Health.

Lord Hunt of Kings Heath Portrait Lord Hunt of Kings Heath (Lab)
- Hansard - - - Excerpts

That makes sense, because clearly, the ICB itself is accountable to the Secretary of State and is generally acting under delegated powers. Clearly, the mayoral nominee is accountable to the mayor. Hopefully, because there is joint responsibility, that will work well. However, the noble Baroness, Lady Bennett, will then ask why Clause 24 is abolishing the partnerships between health and local government.

There is another question about delegation and devolution. I have been surprised that the arrangements in Greater Manchester, where the combined authority has much wider responsibilities in relation to the NHS than in other parts of the country, have not been extended to other parts of the country.

The noble Lord, Lord Stevens, is not in his place, but those changes were made basically because George Osborne reached an agreement with the chief executive and mayor of Manchester City Council. It was done without consulting NHS England, which had just been announced, and it fought tooth and nail against it. That is a great pity. I am not saying that everything is rosy in Greater Manchester—as a West Midlander, I have views on that—but there is no doubt that there is strong evidence, and I have seen research by Manchester University, to show that there have been improved outcomes because of that partnership. What one is really looking for here is some assurance from the Government that they recognise that they need to go further. We need to get this partnership working. If ever one wanted a reason for it, the Milburn report refers to the role of mayors in trying to deal with the horrendous problem we have with young people at the moment. It must have a strong health element.

I am afraid this is a bit of a disparate group of amendments. It all comes back to the same thing: recognising that health and local government have to work together. I hope that the Government can respond in a way that gives us confidence that they recognise that, and that we can build on that in future.

--- Later in debate ---
Baroness Finlay of Llandaff Portrait Baroness Finlay of Llandaff (CB)
- View Speech - Hansard - - - Excerpts

My Lords, I will speak briefly on women’s health hubs. I declare an interest; in my role as chair of the Bevan Commission in Wales, I have been mentoring Alan Treharne, a gynaecologist who has set up a women’s health hub in Ceredigion. It is a remote area, with a lot of people coming from rural communities, with very low health literacy among some of the women who have come forward. He has found phenomenal savings to the NHS and a much faster track—particularly for those with abnormal uterine bleeding who need pre-operative planning or who have post-menopausal bleeding and are particularly anxious—and an ability to triage appropriately.

The lessons from this are that the hub is not just a place for people to go. It must be equipped with adequate diagnostic facilities. It must have up-to-date ultrasound, so it can do transvaginal ultrasound and a virtual hysteroscopy to avoid women having to have an invasive procedure. It must have all those facilities there, linked with contraceptive-type services and so on, so that it truly becomes a one-stop shop that people can feel comfortable with and where they can be fast-tracked to a very high quality of accurate diagnosis.

Lord Scriven Portrait Lord Scriven (LD)
- View Speech - Hansard - -

My Lords, this been a thoughtful debate but a pretty depressing one when you think about it—not the contributions but the concept that, through legislation, we are having to ask people in a system to work together to improve services for the people who they serve. Fundamentally, that is the basis of these amendments, but it does not detract from the importance of raising the issues and us having the discussion.

Let me say from the outset that, unlike the noble Lord, Lord Redwood, we on these Benches support the direction of travel in this group. Integration, collaboration and co-operation are the right ambitions. I would have thought that nobody in the Committee would argue for fragmentation, duplication and services working against each other, but that is precisely my worry. Integration has become one of those words that everybody agrees with and almost nobody delivers. Too often in the NHS, integration is a slogan rather than a reality. Every Health Act I can remember has promised it, every reorganisation has been sold on it, and integrated care boards even have the word in their very title. Yet ask anyone who has spent time in a hospital—as a patient, relative or even as a member of staff—and they will describe something quite different.

Even inside one hospital, integration between services can be a no-go area. Departments on the same corridor operate as though they are in different countries. If that is the picture inside one building, think about what it is like across the whole patient pathway. A frail old person goes from a GP to A&E, to an acute ward, to a community bed and back home to a social care package, and each step is run by a different organisation with a different budget, different IT system, different targets and a different board. For the patient and their family, the experience across the health and care system can be a nightmare.

This is where I completely disagree with the noble Lord, Lord Redwood. The issue is not integration; it is about accountability for the whole patient pathway. Fragmentation means that accountability is less likely for the whole service.

Lord Redwood Portrait Lord Redwood (Con)
- Hansard - - - Excerpts

I was talking about trying to integrate between different bodies. I entirely agree that there should be one doctor responsible for the whole patient progress within a single hospital.

Lord Scriven Portrait Lord Scriven (LD)
- Hansard - -

The noble Lord makes my point. A person does not necessarily have one doctor or one service; they have multiple needs. Therefore, accountability is not brought about by greater fragmentation; it is about thinking about accountability for the whole pathway, rather than different bits of it. That doctor will have accountability for only part of potentially myriad services that the patient requires. Nobody intends it, nobody designs it and nobody is accountable for the whole. That is what we have to think about.

The amendment from the noble Lord, Lord Hunt, requiring a report on the duties to co-operate under Sections 72 and 82 of the 2006 Act, is indeed very sensible. These duties have been on the statute book for a long time, so it is fair to ask a simple question: have they made any measurable difference? If the honest answer is not much then we need to know why before we pile on further duties.

The proposed new clause from the noble Baroness, Lady Bennett, would place a duty on integrated care boards to promote collaboration and to consider the effect of commissioning decisions on continuity and long-term provision. That captures something important. Commissioning that unnecessarily fragments a service carries a cost, even when it looks efficient on a spreadsheet. The requirement to publish an assessment in the annual report would add transparency and, importantly, may change some management behaviour.

Our opposition to Clause 24 standing part raises a real question, which the noble Lord, Lord Hunt, talked about. Clause 24 abolishes integrated care partnerships and integrated care strategies. That is the statutory forum that brings the NHS and local government round the same table, with a duty to produce a shared strategy built on the joint strategic needs assessment. It is hard to reconcile a Bill that talks about integration with a clause that removes one of the few statutory bridges between health and local government.

This is where I accept what the noble, Lord, Lord Hunt, said: this is a pre-Burnham prime ministerial Bill. There is a serious question for the Minister to come back to on Report: in light of the fact that the rewiring the state Bill and outcomes are not ready, would it not be wise to drop this whole part of the Bill and keep things as they are, so that when the rewiring the state Bill comes, we can have an integrated health and local government devolution approach, rather than what we are trying to do, which is to come up with a system for health and then later to come up with a system for local government? History tells us that that will not work. I know the Minister will not be able to give that commitment at the Dispatch Box, but I hope she will commit to go away and talk to government and to come back on Report to say whether it is feasible. It is a genuinely helpful suggestion, based on my own personal experience as a former NHS manager and a former council leader. It is a sensible thing to think about.

The amendment from the noble Lord, Lord Hunt, on women’s centres deserves particular attention. Many noble Lords have talked about why those centres are important. The amendment recognises that the NHS too often forgets that some of its best routes into care and outcomes do not start in the NHS at all; they start in trusted local community organisations that reach women experiencing multiple disadvantages—women who the formal system frequently fails to reach. Bringing them into planning and commissioning is integration in the truest sense: built around the person, not the institution, bottom-up and rooted in the community. I commend the noble Lord for his amendment and those who have spoken to it, and I suggest that the Minister accepts it.

I have to be candid with the Committee: each of these amendments, valuable as they are, adds to the duty to co-operate on top of a system whose very structure works against co-operation. We keep asking organisations to collaborate while designing a system that rewards them for not doing so. The bigger picture—I accept that it is a bigger debate than this group can resolve—is how the NHS is separated into different funding pots and autonomous trusts and organisations. Acute, community, mental health trusts, primary care, social care, and public health are each funded differently, governed separately and held to account for their own bit of the journey. Each can be judged a success, while the patient’s experience as a whole is a failure. While the Minister may be positive about some of these amendments, the true issues we have to look at are who is responsible for the whole of patient care, how it is funded, and whether the Bill will deal with real integration.

I finish by saying again that I hope that the Minister will think carefully about the rewiring of the state and what is suggested in here, and that she will try to come back with an integrated Bill rather than two parts.

Lord Kamall Portrait Lord Kamall (Con)
- View Speech - Hansard - - - Excerpts

My Lords, I thank all noble Lords who have spoken to their amendments in this group, which clearly raise important questions about how our system of health and care works together with voluntary and community organisations in meaningful way. We should welcome efforts to improve co-ordination and co-operation between local authorities, NHS bodies and voluntary organisations. Each can bring their different experience and expertise, notwithstanding some of the comments made by my noble friend Lord Redwood.

To look at some of those organisations, the noble Lord, Lord Hunt of Kings Heath, and the noble Baroness, Lady Royall of Blaisdon, are absolutely right to highlight the valuable role that women’s centres play, particularly when women face complex circumstances and might find it difficult to access or trust what we consider conventional health services. Given that those centres are quite often in the community and community-led, they are run by people who are trusted by very vulnerable women who do not trust the system otherwise. As other noble Lords have said, some of those women may have been offenders or repeat offenders, and the centres keep them out of the criminal justice system when they find themselves in bad conditions through no fault of their own.

This area is important not only in respect of women’s centres. Noble Lords will have heard me speak about my scepticism about, for example, top-down public health. Local community-led public health organisations include those such as BRITE Box, which goes into families’ kitchens and helps them learn to cook and eat healthily, often on a budget, and Intergenerational Music Making, which brings people of different generations, age groups and abilities together around music, often tackling isolation and loneliness. Such organisations are far more effective and can make much more of a contribution to improving the health and well-being of our nation at an aggregate level.

--- Later in debate ---
Moved by
104ZA: After Clause 29, insert the following new Clause—
“Special Health Authority hosting NHS regional teams: accountability and finance(1) A Special Health Authority may not be established for the purpose of hosting the regional teams of NHS England until the Secretary of State has laid before each House of Parliament a report setting out—(a) the functions to be exercised by that Authority, including any functions of the Secretary of State,(b) the one-off and annual costs of that Authority,(c) the person who will be accounting officer for that Authority,(d) each post in the Department of Health and Social Care to be held at Permanent Secretary level, and the responsibilities of each such post, including for overseeing that Authority,(e) the post holder or post holders to be designated as accounting officer for health service expenditure, including expenditure by that Authority,(f) which post holder will have final responsibility, under the Secretary of State, for that expenditure and for the performance of the regional teams, and how any disagreement between post holders about those matters will be resolved,(g) the annual cost of the posts in paragraph (d) and their supporting offices, compared with the equivalent costs in the Department and NHS England on 31 March 2025,(h) an estimate of the transition costs of the arrangements of which that Authority forms part, including exit, information technology and estates costs,(i) the staffing assumptions on which the expected annual savings from those arrangements are based, including whether staff of that Authority are counted, and(j) an updated impact assessment reflecting those matters.(2) An Authority established for that purpose must be abolished no later than two years after the day on which it is established, unless regulations made by statutory instrument, by the Secretary of State, extend that period.(3) A statutory instrument containing regulations under this section may not be made unless a draft of the instrument has been laid before, and approved by a resolution of, each House of Parliament.”Member’s explanatory statement
This new Clause is a probing amendment that would require a report to Parliament before a special health authority for NHS regional teams is established.
Lord Scriven Portrait Lord Scriven (LD)
- Hansard - -

My Lords, I am grateful to the noble Lord, Lord Stevens of Birmingham, and the noble Earl, Lord Howe, for adding their names to Amendment 104ZA. Between them, they have been in charge of legislation for NHS England and have been in the most senior leadership roles of running it. I, for one, have not had enough of experts, so I am looking forward to what they have to say on this amendment.

This amendment is about a body that did not exist when this Committee began: the transitional special health authority for NHS England’s seven regional teams, which was announced on 4 November after we debated Clause 1. We are told that it is temporary, yet, according to the Health Service Journal, NHS England’s chief operating officer told staff that the word “transitional” must be used,

“not because we’re imagining that it’s a time-limited organisation”.

The chief executive of NHS England then said to the same staff that it was time-limited, but no one could say how time-limited. So, it is temporary, but without a time limit. In Whitehall, nothing lasts quite like the temporary.

Consider what we do not know about these regional offices and the special health authority. We do not know how many staff will transfer, we do not know its budget, we do not know what it will lead for, and we do not know who will lead it. Will it have a chief executive of its own or seven regional directors reporting upwards? We do not know where it is going to go after the temporary arrangement ends. Does it go back into ICBs, back into the department, to the mayoral authorities or nowhere at all?

What we do know is that the regional staff keep their NHS pay and conditions, which a Health Service Journal analysis put at, on average, more than £9,500 a year above the department’s for equivalent posts. I can see the recruitment advert now: “Join the special health authority: better pay, with no end date”. This raises a serious issue about recruitment and retention for roles that are transferred to the department. How would the Government plan for that potential move of staff out of the department into the higher-paid, non-Civil Service roles in the special health authority?

Then there are the savings. When abolition was announced, NHS England and the department employed about 19,000 people, and Ministers pledged to halve that. Some 20 months on, it is still almost 17,000. At that rate, the target will be met sometime in the early 2030s, comfortably after the temporary authority has become permanent. The Minister has told this House that the 50% cut is an ambition, not a target. Ministers promised that there would be savings of £1 billion a year by the end of this Parliament, while the restructuring could cost up to £1.3 billion in one-off payments, so the savings are an ambition and the costs are a certainty.

Meanwhile, the Government have finally found a waiting list that they can grow: the waiting list for redundancy. Staff in one ICB cluster waited two months for NHS England to sign off their departures. NHS England, which has been abolished, is approving other people’s exits while it is waiting for its own. Perhaps the Minister could give them a target. Could I suggest 18 weeks?

What concerns me most are the powers. The Bill hands the Secretary of State a long list of NHS England’s powers, and some new ones also: a broad power to direct ICBs; the appointment, in certain circumstances, of chairs and non-executives of local NHS bodies; and intervention in foundation trusts, including deauthorising them and capping their revenue spending. The Secretary of State can already direct a special health authority to exercise its health service functions, and Clause 28 widens those powers. The letter to all Peers confirms that functions of the Secretary of State can be conferred on this new special health authority.

The statement says that it will not exercise national functions. However, directing the ICB in South Yorkshire is not a national function and appointing the chair of an ICB with problems in the south-west is not a national function. These are precisely the regional functions that this body could be given. Think of how inappropriate it would be for a regional office to appoint the chair of a failing ICB and then mark that organisation’s homework on improvement. The Bill even contemplates a special health authority being given the powers to impose financial penalties—a temporary body handing out potentially permanent fines.

We are told that abolishing NHS England would bring management of the NHS back into democratic control. It is a curious kind of democratic control that takes powers from one quango, gives them to the Minister and then posts them out to another quango by a direction that neither House votes on. That is why proposed new paragraph (a) asks the Government to say, before the body is created, exactly what functions it will exercise.

Let me give noble Lords a concrete example. South Yorkshire has appointed the country’s first deputy mayor for health, Sir Steve Houghton, who also chairs the integrated care board and its £4.6 billion commissioning budget. Here I must correct the record. I spoke earlier to the noble Lord, Lord Hunt, about who he would be accountable to. Having looked again at the Government’s own press release, it says that the role jointly reports to NHS England and the elected mayor. From 1 April, one of those two will not exist. I put the direct question to the Minister: will the new special health authority, via the regional officers, be able to direct him? If the Secretary of State’s powers to direct ICBs is conferred on it, the answer is yes. So who does South Yorkshire’s health commissioner actually work to? Is it the mayor, who people elected; the special health regional office, which nobody elected; the NHS group in the department; or the Secretary of State?

Picture the first real disagreement. The mayor wants money moved into prevention. He seeks investment in housing to prevent damp and mould, wanting to keep people out of hospital. The special health authority, via the regional office, wants waiting lists down by March. Only one can win. Who has the final say? If it is the mayor, put it in the Bill. If it is the special health authority regional officers, stop calling this devolution. Devolution where an unelected regional body can overrule an elected mayor is not devolution; it is delegation with a very shiny badge on it.

Lord Hunt of Kings Heath Portrait Lord Hunt of Kings Heath (Lab)
- Hansard - - - Excerpts

My Lords, the whole point is that, when it comes to the health service, we are talking about delegation because of the national nature of the NHS. If you look at what happened in Greater Manchester, it was delegation and not devolution. We need to be very clear that anything that undermines the national nature of the NHS is always going to cause a problem.

Lord Scriven Portrait Lord Scriven (LD)
- Hansard - -

Devolution is not the word that I am using; it is language that the Government are using in selling the Bill. Maybe the Minister can answer the very important point that the noble Lord has just raised.

If the answer is that they will work it out together, that is not a governance model; it really is hope over reality. When it goes wrong, the people of Barnsley, Doncaster, Rotherham and Sheffield deserve to know whose door to knock on. That is precisely what proposed new paragraph (f) in this amendment asks: who holds final responsibility and accountability, and how will disagreements be resolved?

Above all this, sit three Permanent Secretary-level posts—three people who can claim to have the final word usually means that nobody has it. I can already hear the answer delivered by the Secretary of State at the Dispatch Box when something goes wrong: “This is an operational matter that the NHS group and the regional officers need to do. But it may be the system, so I will undertake an independent review. It will be carried out and lessons will be learned”.

I hope the Minister will answer these questions today or in writing before Report. First, on 28 October, when I asked the Minister a direct question about whether a stand-alone body was going to be set up, she told the Committee that the intention was to move all staff into the department. But eight days later, in the other place, a special health authority was already being described as a new regional management tier. I do not question the Minister’s good faith, but when was this decision taken and by whom?

--- Later in debate ---
Baroness Merron Portrait Baroness Merron (Lab)
- View Speech - Hansard - - - Excerpts

My Lords, I appreciate the debate we have just had and the questions that have been put. I will answer some of the headline questions but I will write answers to others, in view of the time. Overall, I reassure the noble Lord, Lord Scriven, and express my appreciation for my noble friend Lord Hunt’s support. The noble Lord, Lord Stevens, used the word pragmatic about establishing a special health authority; it is rather important that we come back to that, because that is exactly what we are doing. Parliament has already provided a very clear process for establishing special health authorities under Section 28 of the National Health Service Act 2006, so it is not an unusual or random thing, or something that we have just come up with; it dates back to then.

To answer some of the questions in broad terms about establishing the special health authorities: we will follow the process set out in that legislation. We will set out the authority’s general functions, governance arrangements and appointments in the establishment order and regulations, which, as statutory instruments, will be subject to scrutiny by both Houses of Parliament in the usual way.

The noble Earl, Lord Howe, raised a question—I hesitate to put words into his mouth, but I will summarise it as I heard it—about whether this is just NHS England being reincarnated in some way. No, it is not. NHS England is a national organisation. It has wide-ranging statutory and operational responsibilities. A special health authority would very much be a smaller body with a narrow, regional remit. It would not be a new national HQ for the NHS; there is no national policy or operational role, and we will not allocate resources across the National Health Service. Those responsibilities would be with the department, with ICBs or with other appropriate organisations.

The authority will be directly accountable to the Secretary of State, so there will be clear democratic oversight. Where a direction is necessary, we expect the special health authority to work closely with Ministers to determine what action is needed. The Government very much recognise the importance of financial oversight throughout this transition, including costs, savings and value for money. Costs will be set out through the usual financial reporting processes. We do not expect the organisational home of the regions to materially affect their overall size or cost.

On some of the points that the noble Lord, Lord Scriven, raised, we have signalled that this should be a temporary arrangement—and I shall use another word that the noble Lord referred to—that will support the transition to a more devolved model, reflecting the fact that regional arrangements that we are putting in place for 1 April next year may evolve depending on how the NHS develops, including the ways they support local areas as devolution continues. The devolution agenda is still emerging, so we do not wish to set an arbitrary countdown for any subsequent reform. It is not an omission; it is just a reality that we find ourselves with.

The additional statutory requirements in Amendment 104ZA would overlap with existing requirements. We believe they would add process and risk delay, and we therefore consider it unnecessary. I absolutely recognise Parliament’s legitimate interest in this process, and we will keep Parliament appropriately informed. Noble Lords will be pleased for me to remind them that tomorrow there is an information session where they will have the opportunity to discuss the details of this. That is one way in which we will do this.

I will refer only briefly to Amendment 279QB tabled by the noble Lord, Lord Blencathra, on the basis that nobody spoke to it—I think that is correct. Safeguards are in place. We have voluntary redundancy programmes implemented within NHS England, commissioning support units and integrated care boards. They all include contractual exit arrangements that require all employees who leave under voluntary redundancy and then obtain employment with another NHS employer up to 12 months afterwards to repay some or all of their redundancy payments. My noble friend Lord Hunt made a very direct assessment of the amendment. I can more politely say that we think the requirements in the amendment are disproportionate and would be unnecessary in that they would restrict NHS organisations from recruiting experienced staff where their skills are needed, so it would go significantly further without adding anything.

Lord Scriven Portrait Lord Scriven (LD)
- View Speech - Hansard - -

My Lords, because of the hour, I will be very brief. I thank all noble Lords who have spoken in the debate. We have prodded, poked and tried to get answers. I appreciate that the Minister has given us an overview. To use the Tears for Fears song “Woman in Chains”, I feel that the chains of responsibility are there. To use another Tears for Fears song, we asked her to “Break it Down Again”, but at this moment she is not able to break down exactly what will happen.

I understand that it is pragmatic and there may be issues that the Government will use in the special authority, but the key is that there are five months before 1 April when all this has to be in place. As the noble Baroness, Lady Thornton, said on a previous amendment, this is a Bill of moving parts. It has now become a Bill of new parts with great uncertainty. I am sure we will want to return to this before Report, and I hope the Minister can answer some of those questions in more detail. With that said, I beg leave to withdraw the amendment.

Amendment 104ZA withdrawn.
Baroness Merron Portrait Baroness Merron (Lab)
- Hansard - - - Excerpts

I am not able to confirm the exact date, but I can say, as I said earlier, that the decision will be announced formally, so noble Lords will be made aware.

On the questions of security, resilience and sovereign capability, as raised in Amendments 53, 171 and 289 by the noble Lord, Lord Tarassenko, the Government share his determination to protect patient data and to support the strong UK digital health market. However, I am not able to commit to an NHS digital sovereignty strategy, nor additional legislation. Supply risk is not determined by nationality or jurisdiction alone. What matters is the data involved, who can access it, the supplies controls and the contractual protections in place. We already have robust safeguards. The Procurement Act 2023, about which much has been spoken, provides powers to exclude suppliers where appropriate, including on national security grounds. It also provides for setting data protection and cyber security requirements.

I note specifically the noble Lord’s concerns about the procurement of the single patient record, and I am looking forward to a more focused discussion, as I know all noble Lords are, on the SPR at a later Committee stage. I can confirm now that the procurement will have to ensure the resilience of our systems, how we keep within the UK jurisdiction and that the data remains under NHS control. The noble Lord, Lord Tarassenko, raised concerns that foreign laws could require an overseas supplier to give access to NHS data. We take that risk extremely seriously and aim to ensure that the legal, contractual and cyber-security safeguards are in place to avoid this.

I fully endorse encouraging domestic innovation, as I hope noble Lords are aware. As the Chancellor set out in the recent Budget, the Government will use public procurement strategically to back British firms to strengthen domestic capability and to build resilience in key supply chains. We will continue to promote international investment and trade and to open opportunities for British businesses at home and in markets around the world.

The noble Baroness, Lady Kidron, indicated her agreement with the noble Lord, Lord Tarassenko, in this area. The points on sovereign data being an asset will come back in the group beginning with Amendment 142, and again I look forward to debating that. We want a vibrant UK market for tech, and practical action is already under way. NHS England is engaging industry ahead of procurements, structuring opportunities to increase SME participation, and using social value to support good jobs and skills, which we all want to see.

I turn to Amendment 279A, tabled by the noble Lord, Lord Austin. He too raises the important question of accountability within this amendment, and we agree that contracting authorities should be accountable to the objectives of the Procurement Act, which already apply directly to covered procurement. The Act also provides transparency and oversight mechanisms, including powers to investigate compliance. The Procurement Act 2023 already requires publication of contract details for contracts worth over £5 million and, where applicable, key performance indicators and annual assessments of supplier performance against them. This makes a further NHS-specific annual reporting duty unnecessary in our view. For medtech, our value-based procurement approach further supports decisions focused on patient outcomes, total care costs, and longer-term value.

Lord Scriven Portrait Lord Scriven (LD)
- Hansard - -

The amendment from the noble Lord, Lord Austin, refers to

“medical devices, consumables and services”.

There are two laws in place for procurement for the NHS: one for services and one for goods. What about the services? We have heard about the goods, but what about the accountability and feedback for services?

Baroness Merron Portrait Baroness Merron (Lab)
- Hansard - - - Excerpts

I made reference to the Procurement Act 2023, and that is the guide by which we go.

Lord Scriven Portrait Lord Scriven (LD)
- Hansard - -

It is for goods, but NHS services come under the 2022 health Act. There was discussion about whether it should have all fallen under one procurement law, but for NHS goods it is the 2023 Act, and for services it is the 2022 health Act that is applicable. If the Minister could write to me and place a copy in the Library, it would be helpful to see how the health Act also applies.

--- Later in debate ---
Baroness Cass Portrait Baroness Cass (CB)
- View Speech - Hansard - - - Excerpts

My Lords, I am sorry that the noble Baroness, Lady Walmsley, is not able to be in her place this evening. I had the privilege of serving on the Childhood Vaccinations Committee, which she very ably chaired. I think it will produce a report which Members of the House will find informative and helpful, and I hope the Government will feel similarly. During the course of that report, we spent a long time talking about the relative impact of problems in access and in vaccine hesitancy. Within vaccine hesitancy, multiple different factors affect how parents feel about vaccinating their child. Among those is medical disinformation. We need to understand more about that and what vaccination and the risks mean to different communities and cultures. Much of that work happens on the ground, on the front line, with community leaders, health visitors and GPs working locally. However, that is not a reason for us not to take a national strategic approach.

The second reason I signed this amendment is that it uses the term “medical disinformation strategy” and talks about anti-vaccination and medical disinformation. The Government need to think about how we tackle medical disinformation much more broadly than just within the vaccine arena. I have talked often enough in this House about my review, but I have not on any occasion put on record what it felt like to do that review and, more particularly, what it felt like and has continued to feel like in the two years since.

The disinformation about my review started six hours before the report was released. It was a funded disinformation campaign, and it continues to date. One of the extraordinary things that were said was that I did not speak to any trans people during the review. We spoke to the support and advocacy groups every four weeks and I spoke to the gender clinicians working at the Tavistock every two weeks. It was said that we threw out 98% of the papers on the subject, which was clearly nonsense. It was said that we did not publish the name of the author of the review—and what did “CASS” stand for, by the way? That was probably one of the most extraordinary ones. Then there are those that I take less seriously, which are more recent, on why I have supported the puberty blocker trial. These range from my being the victim of a Russian kompromat, having a trans child of my own, and—this is the best one—that somebody has kidnapped my cat and is holding it to ransom. I am not particularly concerned about the personal attacks, of which there are many, but I am concerned about the disinformation that misleads children, young people, families and clinicians who are looking after them.

During those last two years after the review, I worked first for NHS England. I declare that I am currently an independent adviser for the DHSC. Colleagues have been supportive, but the burden of what to do about the direct disinformation at the end of the day rested with me. DSIT, as it was, seemed to be the locus of how we dealt with disinformation at that time, but it did not own the strategy, and neither did NHS England or the DHSC—although the DHSC has been very supportive in trying to get a communication strategy in more recent times.

My point in going through all this is not as a “poor me” about my experiences, but because it should never come as a surprise to us that there is disinformation, which is going to be an increasing problem going forward. It is no more surprising than bed pressures and flu in winter. Therefore, I suggest to the Minister, who has been exceptionally supportive to me over these matters, that, in thinking about the structures of the NHS, we need to consider strategically how we will be prepared for disinformation strategies, not just in vaccine services or gender services but in many areas as they arise.

Lord Scriven Portrait Lord Scriven (LD)
- View Speech - Hansard - -

I will quickly talk about my noble friend’s Amendment 224, on the public health duty of Ministers of the Crown. I think most noble Lords would agree that, if we are going to deal with prevention and the determinants of health, it goes far beyond the department to deal with the issues there.

It is always interesting and actually vital to read final impact assessments, because you will find little gems in them. In the final impact assessment on abolishing NHS England, it says:

“The Secretary of State will retain existing public health”


duties. But the NHS England functions to be repealed are not given to the Secretary of State. It says:

“NHS England’s duty to consult with public health professionals to obtain advice on the discharge of its functions will be repealed and not transferred to the Secretary of State”.


I have a very simple question for the Minister. I declare an interest in that my husband is a former director of public health. Anybody in the medical world who comes into contact with a doctor from public health will say that they are a very strange creature; living with one, I can confirm that is the case—but professionally, they look at things very differently. They are not about one part of the body or one disease; they take a much more holistic approach to the determinants of health and population health. Why is the Secretary of State retaining public health functions but not taking NHS England’s function to sit down with, listen to and consult public health professionals when carrying out those directions? It seems a very strange system to take the functions but not have the duty to sit down with and listen to public health officials. If that duty is not transferred to the Secretary of State, what body in law does the Secretary of State have to sit down with and listen to that is composed primarily of public health professionals?

Baroness Pidgeon Portrait Baroness Pidgeon (LD)
- View Speech - Hansard - - - Excerpts

My Lords, I shall speak to Amendments 223, 224 and 231 in the name of my noble friend Lady Walmsley, who cannot be in her place today.

Amendment 223 would require Secretary of State to lay before Parliament an annual report on the performance of routine, seasonal and targeted immunisation programmes, which sets out the action plan for the coming year to address areas of low vaccine uptake. The report must also cover all eligible cohorts within the national immunisation programme, use consistent measures across programmes and include data that enables inequalities in vaccine uptake to be tracked by geography and population group. It should be in addition to existing vaccination coverage reporting. This would enable vaccine accountability and make sure it remains visible following the removal of Section 7A, with clear reporting on how national oversight is being maintained and how delegated responsibilities to ICBs and providers are being delivered.

--- Later in debate ---
Baroness Scott of Needham Market Portrait Baroness Scott of Needham Market (LD)
- View Speech - Hansard - - - Excerpts

My Lords, I have tabled Amendment 65 to Clause 15 on the topic of accessible patient involvement. It seeks to ensure that the arrangements for involving patients in commissioning decisions are accessible to those living with long-term, complex or fluctuating health conditions. I welcome the Government’s decision to retain and strengthen Healthwatch England and local Healthwatch organisations. It is an important recognition of the value of independent patient voice, and I am pleased that Ministers have listened to the concerns raised across both Houses and beyond. However, retaining that independent patient representation is only part of the picture. We must also ensure that the mechanisms through which patients are consulted and involved in the decisions which affect their care are genuinely accessible.

I take a close interest in ME. I have a family member with it and I am a member of the all-party group. For people living with severe or very severe ME, conventional forms of consultation can be extremely difficult and quite often impossible. Attending meetings, participating in lengthy phone calls or completing detailed questionnaires can worsen some symptoms considerably. I have spoken about ME, but there are many other conditions for which the same can be said. If patient involvement arrangements are not designed with these limitations in mind, there is a real risk that those people with the greatest need will have the least opportunity to influence the services which should be supporting them.

This concern is particularly relevant given the evidence of poor access to services now. Action for ME’s 2026 big survey gathered responses from more than 5,000 people living with ME and long Covid. They found that 83% of respondents reported barriers to accessing NHS ME services. I was also struck by the large number in the survey who were not able to access any kind of healthcare at all, including routine screening. This is totally unacceptable. We cannot expect services to meet the needs of these patients if they are effectively excluded from the decisions about how those services are designed and commissioned.

My amendment is very modest. It would require the Secretary of State to take reasonable steps to ensure that patient involvement arrangements are accessible and inclusive, with particular regard to disabled people and those with long-term, complex or fluctuating conditions. This could mean greater flexibility in how people contribute and how they are consulted. It needs to recognise the particular circumstances in which patients can participate. It will require a little imagination and quite a lot of empathy, but it ought to be possible. I would therefore welcome the Minister’s assurance that these patients will not be overlooked in the Government’s arrangements for patient involvement and ask whether she would consider putting something in the guidance to make sure that it happens.

Lord Scriven Portrait Lord Scriven (LD)
- View Speech - Hansard - -

It is a pleasure to follow my noble friend. I want to come back to the points that the noble Lord, Lord Hunt, made. I believe we are coming to a point in this Bill for us to make reasonable amendments and suggestions. Either we can continue to go down the road without the detail and let the service reorganise itself, or we can start to get some serious detail, particularly regarding specialised commissioning and the capacity of ICBs.

Just to understand, there are about 154 specialised services that are commissioned. Already, around 70 of those are commissioned via ICBs under delegated direction from NHS England, and the rest are commissioned centrally by NHS England. What the Government are asking is for the cuts to be made to staff, for the staff to go, and then for the detailed skills and knowledge that are required for the specialised commissioning to come after that process. The National Audit Office has put out a report which questions, even on existing duties, whether ICBs have the skills, knowledge and breadth to carry out what the Government want.

With these extra services, it could be that ICBs, the delegated strategic commissioners, cannot commission what Government wish them to commission. The noble Lord, Lord Hunt, and I both got quite cross with the then Minister, the noble Lord, Lord Kamall, during the passage of the 2022 Act, that things were happening in the system before Parliament had made the decision. That is what is beginning to happen again; things are happening. The offices for pan-ICB commissioning are not new; they were asked to be determined in April 2026. They were in the impact assessment for the abolition of NHS England, so they are already known about. The key issue is: what services are they going to have to give a joint response for? Will we have the list of specialised commissioning services carried out by ICBs and the Secretary of State by Report? Is that a commitment the Minister can give? If not, we cannot make a reasonable decision on Report about specialised commissioning with the depth and breadth of knowledge that is required. Can the Minister give us that commitment?

As the offices for pan-ICB commissioning—OPICs—were selected in April, can the Minister commit to giving us their duties and the budgets they will have, or will be able to direct, in writing before Report? What powers of direction will the Secretary of State have for consistency of ICB specialised commissioning, and can those be with us by Report? These are important questions that need to be answered because, if not, we will be getting to Report, being asked to support specialised commissioning with two bodies—the Secretary of State and ICBs—and, particularly for ICBs, we will not know whether they have the capacity to do it. I do not think that this House will be able to make a decision about whether it is reasonable, safe or justified for us to continue suggesting that this is a route for ICBs to commission.

Baroness Cass Portrait Baroness Cass (CB)
- View Speech - Hansard - - - Excerpts

Briefly, I support the comments of my noble friend Lady Grey-Thompson and the noble Lord, Lord Hunt, and thank the noble Baroness, Lady Pidgeon, for Amendment 59, which I fully support. It is all right for me to support all of these people, because according to the best disinformation sources, I am in the pay of the Tories, but not the other parties. I did hesitate over whether I should allow a friend on the Opposition Benches to buy me a cup of tea the other day.

On a serious note, I worry, as others do, about ICB capabilities, and my noble friend Lady Finlay and I have spent years struggling with a postcode lottery on the commissioning of specialist palliative care services for children. They are commissioned at the wrong level, and therefore vary hugely from ICB to ICB, and should be commissioned at a higher level. The notion of greater devolution fills me with anxiety, so I fully support that amendment.

Baroness Coffey Portrait Baroness Coffey (Con)
- Hansard - - - Excerpts

My Lords, we have got a Holy Trinity now. We have dealt with how we encourage people to get into and stay in work, we have talked about dentistry, and now we are going to talk about more things to do with urgent care.

This amendment is about promoting equitable access to ambulance services. I feel passionately about this: it was something I dedicated a lot of my time to as an MP, trying to improve access at local level. It was when I learned about how often, on a regional basis, we would see actual manipulation of where ambulances were placed in order to make sure targets were hit—but it did not mean that patients were served well.

There are a number of issues in regard to ambulances, and I pay tribute to many first responders. In the statistics, recorded nationally, a volunteer responder turning up is the same as having a paramedic arrive. In the East of England Ambulance Service, which had started to show improvement but is now really struggling —again—ambulances are quite regularly sent without any qualified paramedics in them.

I come back to the point that this situation can be very serious. Quite often, outside our major cities, for example in the east of England, if you have a stroke or a serious heart issue, you have to go to Cambridge for the best treatment. Stuff has happened along the way to try to make sure that you can stop en route, in places such as Ipswich and Norwich, in order to get something along the way. A stroke is something that causes the greatest harm, in terms of people having a good quality of life later. Of course, having a wide range of first responders across the country is a very useful way to help people who have had either a cardiac arrest or a heart attack, to keep them alive. But the difference in your quality of life depends on how quickly you get treatment when you have had a stroke; it is a real life changer.

One of the things I am conscious of is that we have many rural areas around the country. Something more needs to be done to help rural communities. It also happens to be the case—particularly thinking of coastal areas—that a lot of tourists rely on emergency services when they are on holiday. That is not taken into account in some of the funding measures, as far as I am aware.

I am pleased that we have seen an increase in the number of paramedics, but, reflecting on the point referred to earlier by the noble Baroness, Lady Hollins, on clinical staff in the NHS, it is paramedics who have the highest sickness rates. I think it is more than double —perhaps even treble—how often an average hospital doctor or consultant sadly ends up being off ill. It is not the Cinderella of the NHS, but it is certainly a part of the service that has been forced into mergers over the years, and there is huge reluctance among NHS leaders to break them apart in a way that would perhaps help patients. Indeed, we are effectively seeing many more mergers happening around England, which is going to be a real struggle, particularly for rural communities.

I am grateful to the Minister for sending the letter today about what will be happening. ICBs are taking on dentistry as part of their statutory duties, but there was no reference to what would be happening with ambulance services. I know it is common practice that one ICB tends to do the commissioning on behalf of all ICBs in that area, because they are currently constrained by the fact that they do not have any choice in where they get their ambulance service. I am not suggesting that we go for some free-market approach. We need a sensible, well-connected way of dealing with these emergencies. It would be useful to hear what the Secretary of State’s plans are for the next phase of NHS provision across the country.

I share the concerns, reflected in other amendments in this group, about people suffering corridor care. I look forward to trying to better understand the amendment from the noble Baroness, Lady Pidgeon, regarding 12-hour admissions to A&E. It has become terrible how patients are not being seen, especially when that can be a matter of life and death. I hope that we will have some further useful discussions on this important blue-light service and recognise the contributions made by paramedics and community first responders right across our country. I beg to move.

Lord Scriven Portrait Lord Scriven (LD)
- Hansard - -

I know the noble Baroness likes to be absolutely correct. She said that the highest rate of NHS staff sickness was among ambulance paramedics. It is actually ambulance support staff, which does not include paramedics. I am sure she would like to correct the record.

Baroness Coffey Portrait Baroness Coffey (Con)
- Hansard - - - Excerpts

I am grateful to the noble Lord for doing that. That is not in the information that I have, but I completely accept what he has said. It is unusual in the NHS that the average number of sickness days lost to non-clinical staff is more than double that to clinical staff, but I completely understand the noble Lord’s point.

--- Later in debate ---
Baroness Merron Portrait Baroness Merron (Lab)
- Hansard - - - Excerpts

I take very seriously the point that the noble Baroness made. I am sure it is already being looked into, but I will personally make sure that that is the case.

On corridor care and children, one example of the practical action taken is our recent announcement that the NHS is rolling out a standardised system to spot when a child’s health is deteriorating, so that early warning signs are caught earlier and there is faster action. The paediatric early warning system will be introduced in all emergency departments by the end of 2027-28, with an ambition to also roll this out in ambulance and community settings in the future. This is broader than just corridor care, but I know that that is a particular concern, as I said, when it comes to children. I cannot confirm often enough that we remain committed to fully eliminating corridor care before the end of this Parliament.

Finally, on Amendment 72, in the name of the noble Lord, Lord Patel of Bradford, I can give the reassurance that there is no national policy supporting blanket minimum waits. Indeed, patient safety always comes first. If a commissioner puts capacity measures in place, urgent referrals must be excluded, minimum waits must not be set above 18 weeks and providers must continue to triage patients according to clinical priority.

At the start of the year, it is important and expected that commissioners plan to balance service delivery with their yearly budgets while prioritising patient safety and clinical need. I remind your Lordships’ House that it is due to our approach to financial planning that the NHS stayed in line with its budget in 2025-26 while also cutting waiting lists by over 250,000 between July 2024 and August 2026. Removing the use of tools to support planning could drive unplanned activity and overspending, which would of course undesirably divert resources from other patients.

On the points made by the noble Lord, Lord Patel, about autism and ADHD assessment, expectations have already been set out for ICBs and providers to reduce those long waits and to improve experience, quality and productivity in ADHD services over the next three years. We are moving to a needs-led support model that means earlier access to information and support and appropriate interventions that are individually based, without and before a diagnosis.

On the question about ICBs imposing minimum waits and whether we will publish which ICBs are doing this, there are no plans to publish this information. The data is held locally and that is right, because these are decisions for local areas. To restate what I said before, commissioning decisions are for ICBs to make.

Lord Scriven Portrait Lord Scriven (LD)
- Hansard - -

The Minister just made a very important point. Can she clarify? Is she saying that there is a requirement for ICBs to statutorily report that they have implemented a minimum wait standard, or not?

Moved by
30: Clause 8, page 5, line 7, leave out “relate to the health service” and insert “are public health functions”
Member’s explanatory statement
This amendment, consequential on the amendment in the name of Lord Scriven to replace clause 11, limits delegation directions to ICBs to public health functions.
Lord Scriven Portrait Lord Scriven (LD)
- Hansard - -

My Lords, in speaking to this group, which has many amendments in my name, I will speak in particular to Amendment 40. Amendment 30 is consequential and is a probing amendment. Most of my amendments in this group ask the question why the Secretary of State requires such huge powers of direction. I know that, in the next group, we will come to what happens if the Secretary of State uses those powers of direction. This is a probing amendment, and I will be very clear at the end about exactly why I am probing.

When you abolish a body the size of NHS England, its powers have to land somewhere. In this Bill, they land overwhelmingly on the desk of the Secretary of State. Clause 11 is the heart of that. It gives the Secretary of State a general power to direct integrated care boards on how they exercise their functions. I want to take the Committee through what that power actually does, because I do not think its breadth has been fully grasped. New Section 14Z61 lets the Secretary of State direct a board—one board, several boards, indeed all ICBs—on whether to use a power at all; on when and how a function is exercised; on the conditions to be met first; and on what the board must take into account.

Where an integrated care board’s decision depends on it forming an opinion, the Secretary of State can inform that opinion themselves and direct the ICB to act without forming an opinion at all. The board’s judgment becomes optional. There are three exceptions: there should be no directing the appointment of an aimed individual, the care of an individual patient or treatment contrary to NICE guidance. They are all sensible and my amendment keeps each one, applying them to its commissioners, which I will talk about later. But outside those three exceptions, there is little that the Secretary of State could not direct an integrated care board to do.

Look at what the department told the Delegated Powers and Regulatory Reform Committee: the department’s memorandum is remarkably candid. It concedes that NHS England has no general power to direct boards at all; it can direct only on primary care or where a board is failing or at risk of failing. It concedes that the Secretary of State’s existing

“power to direct NHSE … has only been used on highly technical functions”.

That is not a transfer; it is a brand new power far wider than anything NHS England has ever held dressed up as housekeeping.

How will this be scrutinised? It will not. The memorandum says plainly that there will be “no parliamentary procedure”—neither affirmative nor negative; nothing. Instead, there will just be publication

“as soon as reasonably practicable”

after the event. On the companion power in Clause 8, which will let the Secretary of State order a board to take on any of the Secretary of State’s health functions, the department says that directions are preferred because they act

“without taking up valuable parliamentary time”.

Scrutiny is not a waste of parliamentary time: it is the job of this House and this Parliament.

The memorandum goes further. Directions are chosen, it says, because changes can be made

“more quickly than they would through regulations”

and

“in a level of detail that would not ordinarily be included on the face of primary or secondary legislation”.

Translated, this route is chosen precisely because it avoids Parliament. It tells us that the two powers may be used together to direct a board to take on a function under Clause 8 and then direct how to carry it out under Clause 11. That is not strategic commissioning; it makes the ICBs a branch office of the Secretary of State.

There is an inconsistency, too. The department says that waiting times and patient choice requirements in Clause 16 belong in regulations because they

“need to be consistently applied across the NHS”.

Yet it justifies directions on service specifications and clinical pathways on exactly the same grounds of national consistency. If consistency demands regulations for one, why does it demand no parliamentary procedure at all for others? I note that Clause 16 will omit Section 6E, the existing regulation-making power, and put narrower powers on waiting times, patient choice and appeals in its place. Beyond those, rules that Parliament could see can be replaced by instruction it reads about afterwards.

Even the failure regime in new Section 14Z62A, which will let the Secretary strip an ICB of its functions, sack the chief executive and direct who replaces them, at least requires published reasons. The general power used on an ICB that is doing perfectly well does not even require that. The pattern continues. The Government’s October supplementary memorandum adds yet more direction powers over new maternity and neonatal commissioners and describes no procedure for how to do so. I also note that it describes these as “subordinate legislation”; subordinate legislation that Parliament never sees is a curious creature.

Add the removal of the mandate and the removal of the prescribed content of performance assessments, and the direction of travel is obvious. The things that give ICBs a framework and gave Parliament sight of it are taken out, and the things that allow ministerial instruction are put in. The Health Foundation is right that this hands too much of the day-to-day running of the NHS to Ministers, and a Secretary of State who can direct any ICB on anything will rightly or wrongly be blamed for everything.

My amendment is deliberate in its broadness, as I want to understand the Government’s thinking. I, for one, do not think that it will be accepted by the Government; that is why it is a probing amendment. It does not deny that the Secretary of State must be accountable for the NHS, but it offers a different way of doing it. First, the Secretary of State would set national outcomes for the health service in England, laid before Parliament, with an annual report on progress. That would replace the mandate that the Bill abolishes. Secondly, the Secretary of State would set outcomes for each board, after consulting it and having regard to local needs assessments and neighbourhood health plans. Those outcomes are results for patients, not instructions on means. That is the line between holding to account the NHS and the Secretary of State, and the Secretary of State operationally running it.

--- Later in debate ---
Baroness Merron Portrait Baroness Merron (Lab)
- Hansard - - - Excerpts

My noble friend has put it very clearly and I most grateful. I think the public believe that the Secretary of State has that power already, but in fact she does not, which is a point my noble friend has made on many occasions.

Turning to Amendment 40, I should also draw attention to the distinction we have made between the more routinely used power of direction and the powers specifically reserved for use in cases of significant failure or risk of significant failure. Retaining the distinction between types of direction is important, as is the recognition of when an intervention is undertaken to protect patients, the public or taxpayers. I note the alternative proposal to appoint commissioners from the noble Lord, Lord Scriven, in Amendment 40. My concern is that this approach would likely be more cumbersome and would slow Ministers’ ability to intervene where significant failure was occurring—something that I know noble Lords would not want. Amendment 40 also touches on outcomes frameworks. I assure the noble Lord that I share the sentiment about the importance of outcomes frameworks, and, if necessary, we can complement existing frameworks by using directions.

I will now briefly touch on Amendments 76 and 77, which relate to Clause 21. The clause transfers the requirement to conduct annual assessments of ICBs from NHS England to the Secretary of State and focuses the assessment on the statutory functions of these organisations rather than a narrow list of duties. Currently, the position is that NHS England assesses ICBs annually, using data and local insight to review their performance against their functions, including a list of duties prescribed by the current legislation. The results are published online and they inform the oversight relationship between NHS England and each ICB. However, this list of duties forms a static list of requirements which are already part of the ICBs’ statutory functions. Performance assessments need to adapt to the evolving role of ICBs as strategic commissioners, and evening out the focus across all ICB duties supports that, making assessment more flexible and meaningful as ICBs adapt.

These clauses enable the Secretary of State to support the system, respond to unforeseen challenges and uphold the standards that patients expect and deserve, while ensuring that we have fairness and impartiality at the heart of the National Health Service.

Lord Scriven Portrait Lord Scriven (LD)
- View Speech - Hansard - -

My Lords, I thank all noble Lords who have taken part in this revealing debate on the powers of direction of the Secretary of State. What the debate has drawn out is that it is not as clear-cut as the Minister suggests, and accountability is not the same as having the right to make unfettered decisions about the health service based on nearly every clinical decision or every finance decision in a locality.

Throughout the health service, day by day, many decisions are made for which the Secretary of State is accountable. I do not think any noble Lord is asking that the Secretary of State should not be accountable; it is right that they are, and it is within the accountability framework of the NHS. The issue that noble Lords have raised is what powers the Secretary of State should have over the day-to-day running of health services at a local level. It appears from what some noble Lords have said—the noble Lord, Lord Stevens, the noble Baronesses, Lady Manzoor and Lady Bennett, and the noble Earl, Lord Howe—that in the Bill those powers of direction may be too concentrated in the Secretary of State’s hands. I think we will come back to this on Report. The point raised by the noble Lord, Lord Patel, about clinical expertise being drawn on to make the Secretary of State come up with clinically sound decisions, is really important.

I note that, once they are a Secretary of State or a Minister in the Department of Health, nearly everybody who has been in the department—apart from the noble Earl, Lord Howe—wants the powers. I believe that the power to make the strategic direction of the health service, and to be accountable for that, is the Secretary of State’s, and the power to intervene in an emergency or in unusual circumstances should remain with the Secretary of State. To use the Minister’s point, the intention is not to micromanage but to use the powers sparingly. It is very good to hear that that is the role of the present Government. But, as the noble Lord, Lord Stevens, pointed out, a different Government with a different political stance will be making important decisions that could potentially have an effect on clinical access to services, as well as on where certain services are. I do not think the Minister has answered on that balance to many noble Lords’ satisfaction. We will therefore potentially come back to this on Report, but at this moment I beg leave to withdraw my amendment.

Amendment 30 withdrawn.
--- Later in debate ---
Lord Stevens of Birmingham Portrait Lord Stevens of Birmingham (CB)
- View Speech - Hansard - - - Excerpts

I wonder whether this might be an opportunity for the Minister to set out how the new accountability arrangements would work in practice, because the amendment from the noble Earl, Lord Howe, would rightly require that, in the event that a power of direction is used, a rationale is set forth so that it is clear why a decision was taken and where responsibility for it sits.

One illustration of this might be the situation facing maternity services in Norfolk, which the noble Baroness, Lady Coffey, mentioned. I quickly had a look at the situation there. Of the three hospitals, two had under 2,000 births a year, and the prediction is that, within a decade, two of those three hospitals will be delivering four or fewer births a day. So there is a question about the sustainability and safety of that service. If, in the interests of a political direction, these new powers are used to insist that those small maternity units with a potential safety concern remain open, even though it might be hard to staff them and to provide the level of back-up said to be required, where will accountability for the safety questions sit? Will the Care Quality Commission, when it arrives at those hospitals, do an inspection to determine whether women may be put at risk, if that is the case? Will the Care Quality Commission then issue findings against the Secretary of State—potentially with criminal proceedings in certain circumstances—or against the local provider or the ICB?

To the extent that this group is about the integrated care boards, let us not forget that, as I understand it, the proposed route for direct influence from the Secretary of State to those hospitals in Norfolk would be only partly through the ICB strategic commissioning decision. The performance management function of those hospitals, including the way in which they manage their safety, will now be routed through this new offshore special health authority, which will then route back, on some sort of new vector, directly into the hospitals concerned. Can the Minister explain, in the interests of transparency and political accountability, how will it work in a situation like that? Where will the decision-making sit? When safety concerns are front and centre, will the Secretary of State override the individual provider, and will they do so via the new special health authority or just rely on the commissioning role of the ICB?

Lord Scriven Portrait Lord Scriven (LD)
- View Speech - Hansard - -

My Lords, it is quite a pleasure to follow the noble Lord, Lord Stevens, who asks some important questions about the transparency of the accountability mechanism—particularly since the whole reason for abolishing NHS England was to stop it being a stand-alone body in the department. As he has pointed out, we are abolishing a quango to set up a brand new quango. I look forward to the Minister’s answers on what the accountability mechanism will be if the CQC makes findings into maternity services in Norfolk.

I thank the noble Earl, Lord Howe, for these amendments. We made our position clear in the last group. We do not think that the general power in Clause 11 should exist in its present form, and in the last group we tabled a probing amendment with an alternative based on outcomes. However, if the Government insist on this, Parliament and the public should expect at least what these three amendments offer: a reason, a test and a record of those decisions.

Under the Bill, when the Secretary of State gives a direction under Clauses 8 or 11, they must publish it as soon as “reasonably practicable”. That is all. There is no reason, no duty to consult and nothing on how long it lasts or what it costs. The department’s memorandum to the Delegated Powers and Regulatory Reform Committee confirmed that there is no parliamentary procedure. On Clause 8, the memorandum says that directions avoid taking up “valuable parliamentary time” and that, unlike with voluntary delegation, a directed ICB would be “legally obliged” to carry out that function. It also says that publication means that the power is “used transparently”. Publishing an instruction is not transparency; explaining it would be the transparency that is required.

The Bill already accepts this. Under new Section 14Z62A, the Secretary of State must publish their reasons when they intervene in a board that is failing. A board in significant failure is told why; a board doing perfectly well which is directed under the general power—we should remember that this is a new power to direct an ICB that is not in any way underperforming—is not given a reason why the Secretary of State has decided to intervene. The Government cannot say that giving reasons is impractical when they require it a few lines further on in the Bill.

First, on the reason, the amendments to Clauses 8 and 11 would require a statement within seven working days on the function concerned, the reasons, how long the direction lasts, when it will be reviewed, its financial and operational effects, its effect on the ICB’s local population and who is responsible for what, which is absolutely vital for accountability. The Clause 11 amendment goes further. When subsection (3) is used and a board is made to act without forming its own opinion, the Secretary of State would have to say what opinion they formed and why, and why the board should not be able to form its own. This also matters for money. Clause 8 says that the Secretary of State may make payments, whereas Clause 11 says nothing about funding at all. A direction with no funding moves a cost from Whitehall to local services, and those affected deserve to see that reason.

Secondly, on the test, the memorandum says that directions are needed

“to respond to emerging situations”,

which is absolutely fine, and to secure nationally consistent standards. This amendment would stop neither: proposed new subsection (3D) would let the Secretary of State act first and consult afterwards where there is an urgent risk, with a decision on the direction within 28 days.

Proposed new subsection (3A)(c) expressly counts the benefits of consistency. It simply asks whether guidance, agreement or existing oversight would do the job and whether the direction is necessary and proportionate. It would also require the ICB to be consulted. If the Minister says, as I expect she may, that Ministers intend to act in this way, there is nothing to lose by saying so in the Bill. The Health Foundation has asked Ministers to set out safeguards for how the powers will be used, but we are still waiting for those safeguards and a full explanation.

Thirdly, in relation to the record, the proposed new clause after Clause 22 would put each direction in the board’s annual report: what has changed, what it cost, what risk the ICB warned about, and where responsibility lay. Under Clause 11, an ICB can be directed and, under Clause 21, is assessed on how well it has discharged its functions. Under new Section 14Z62A, failure includes failing to act

“consistently with what the Secretary of State considers to be the interests of the health service”,

and the chief executive can be removed. A board could follow an instruction, see its performance suffer and then be held to account for the subsequent result. Clear responsibility protects the ICB and protects patients.

I will be honest about the limits. None of these amendments gives Parliament a vote. Statements would be published, not laid. The test rests on the Secretary of State being satisfied, and Clause 8 has no such test. There is also a burden: consulting every ICB on a national direction takes time. Some of the drafting needs tidying before Report, but the general principle is one to be welcomed. The Minister may well call this bureaucracy, but if the Secretary of State cannot say within seven working days why they have given a direction, how long it lasts, what it costs and who is responsible, the Secretary of State really needs to think about why that direction has been given in the first place.

I have two very quick questions for the Minister. If reasons are required for a failing board, why not for every board, including boards that are performing well? Most importantly, what happens when an ICB follows an intervention and a direction from a Secretary of State and clinical outcomes or finance get worse? What happens in those circumstances and who, ultimately, will be held responsible? A reason, a test and a record—that is not much to ask of the Secretary of State who is taking so much power. I look forward to the Minister’s replies.

Baroness Merron Portrait Baroness Merron (Lab)
- View Speech - Hansard - - - Excerpts

My Lords, I am most grateful for this debate, particularly following on from the last group. I hope that noble Lords found that the previous group laid some helpful groundwork ahead of addressing Amendments 32, 37, 38 and 86 in relation to Clauses 8, 11 and 25. I am grateful to the noble Lord, Lord Kamall, for tabling Amendment 32, which was spoken to by the noble Earl, Lord Howe.

As I noted in the previous group, I share noble Lords’ commitment to transparency and to the appropriate use of directions. However—this applies to a number of the points that were raised—this needs to be balanced with some caution about overspecifying requirements in the Bill, given that that could well come at the cost of flexibility and speed, which I know noble Lords understand the need for. In some cases, the information required may not be relevant in terms of the amendment. I assure the noble Earl, Lord Howe, that it is currently standard practice for much of the information that is being asked for in the amendment to be included in directions issued by NHS England and the Secretary of State, where it is operationally relevant. I have no expectation that this will change in the future.

The duties of ICBs were raised by the noble Earl, Lord Howe. ICBs will continue to have a duty to commission a comprehensive health service except for those services that are commissioned by the Secretary of State as specialist, and the Secretary of State retains the duty to promote that service.

--- Later in debate ---
Baroness Merron Portrait Baroness Merron (Lab)
- Hansard - - - Excerpts

There is no need for the noble Baroness to apologise; that is what we are seeking to do. The point here is that we are, by definition, confining our discussions to when things are going wrong or there are concerns. It is important to state that all the changes we are making and all the frameworks that are in place—the whole suite of measures—are there to ensure patient safety, the right outcomes and the right service to patients. In this discussion there is inevitably a greater focus on when things go wrong, but we are trying to ensure that things do not go wrong.

Lord Scriven Portrait Lord Scriven (LD)
- Hansard - -

My Lords, many of us are struggling and asking quite basic questions because we still have not seen the operational model or the framework for how the new system will work. Can the Minister give a commitment that, before Report, the operational model will be made available to noble Lords? If not, this is becoming a bit like trying to find your way through a maze while blindfolded. It really is difficult, and that operational model is vital for us to make legislation and help the Government improve it, which is in the interests of patients and the system as a whole.

--- Later in debate ---
Baroness Manzoor Portrait Baroness Manzoor (Con)
- View Speech - Hansard - - - Excerpts

My Lords, I do not want to repeat anything that has been said, and I agree with most of the comments that have been made, except, with apologies, those of the noble Baroness, for the reasons that have been articulated. We have an independent, private and state sector NHS. I was around in the 2000s, and we did an awful lot of commissioning in the independent and charitable sectors and it worked well.

To make this clause much stronger, the real emphasis should be on procurement. There is a real issue when the NHS procures—not thinking of the impact it has on other services being provided by that hospital, and it is usually hospitals. That funding, when things go wrong and that care has been provided by the private sector, reverts back into the NHS. There needs to be some mechanism and recognition of where those costs sit.

When she looks at this clause, the Minister should perhaps also look at what happens to the spare estate facility and capability of those organisations, because they still have rents, rates, electrics, et cetera. That does not get shut down because, irrespective of what we say, there are still block contracts. I know that we have clauses on block contracts, but procurement is very important and we should look at where choice is in the way that the contracts are let out. It is not cherry-picking; for the very simple operations—I think the noble Baroness, Lady Murphy, mentioned cataracts—that is very important. It is not just about the timeliness of things, which is important, but the quality and the outcome of that service that has been provided to that particular patient. I totally support the comments made by my noble friend Lady Coffey. We must put the patient at the heart of this.

Lord Scriven Portrait Lord Scriven (LD)
- View Speech - Hansard - -

My Lord, when we started this group, I did not expect the phrase “the Soviet model of healthcare” to be mentioned, but the noble Baroness, Lady Murphy, used it. It is always surprising what one hears and learns in Committee. From these Benches, our starting point is simple: the principle that defines the NHS is that care is free at the point of use and based on need, not ability, to pay. That is a line that I think most noble Lords would never wish us to cross.

Who owns the building matters less to a patient than whether they get good care in good time, and a good outcome without paying for it. As Liberals, we start from individual patients. We ask what power the patient has, who can take it away and why. I respect what the noble Baroness, Lady Bennett, is trying to do. She is right to raise concerns about profit and public money, but her amendments are the wrong answer. They would take choice from patients, and those with the least would lose most.

Let us take Herefordshire. It is a large, rural county with one NHS acute hospital: the county hospital in Hereford. The next-nearest NHS acute hospitals are in other counties, or even across the border in Wales. Many villages have few buses. The county’s own draft transport plan is still working towards better links between Hereford and market towns. Nuffield Health also has a hospital in Hereford, which provides some NHS services free at the point of use to patients. Under the noble Baroness’s presumption, that option exists only if there is no reasonable public alternative within a clinically appropriate timeframe. The test asks, “how soon?”, but not “how far?”, nor how a pensioner with no car gets to an operation in another country or county, and home again. Care is free at the point of use; the journey is not. For someone on a low income, a free operation that they cannot reach is not much use, nor is it right. A patient on a long waiting list at the only public hospital in their county should be able to choose another provider nearby, free at the point of use—whether that be private or NHS provided. Someone with money can already pay to leave the queue. Taking away that free option would not abolish the two-tier system; I believe it would deepen it.

This also goes well beyond hospitals, as other noble Lords said. The new clause in the amendment after Clause 11 says a service is not publicly provided if it is contracted to a private body, and only public bodies may provide it. As noble Lords said, most GP practices are private contractors, as are many community pharmacists, high street dentists and opticians. They are the front door of the NHS. What about hospices? There are 135 independent adult hospice charities in England. The National Audit Office says the sector cared for about 251,000 people in 2023-24, with the Government funding around 29% of its income. Are those to be taken out or shut down under this amendment? As has already been pointed out, in 2023-24, over half of NHS cataract operations were done by independent providers. Bringing them back at speed into NHS public bodies would lengthen waits for older people to have their cataracts done. The term “private sector body” is not defined in the amendments, so we cannot tell which of these would fall under the presumption.

The review in Amendment 36 is the most useful idea in this group from the noble Baroness, Lady Bennett, but it is framed around returning services to public provision. It should ask a neutral question: which providers—public or independent—give quality, value and fair access, with provision free at the point of use? None of this is a blank cheque for the private sector. Independent providers delivering NHS care must meet the same standards and publish the same data. They should train staff and not pick off the simple cases while the NHS keeps the complex ones. That is part of what ICB strategic commissioning needs to pick up. Independent providers delivered only around 7.5% of NHS planned care in February this year, based on their own trade body’s figures. They are a useful supplement, but they are no substitute for NHS care that is properly and publicly funded.

This brings me to Clause 10. What is the point of it? What problem is it solving? Can the noble Baroness give the Committee an example of what a Secretary of State cannot do now that they could do with this clause? We need to be clear that this clause changes a provision in the 2006 Act which stops the Secretary of State from swinging between private and public. The new clause would allow to happen the very thing that the 2006 Act stopped, depending on how the Secretary of State felt when they got up that morning and decided whether they were in the mood for public or private healthcare. The Committee needs to understand what problem this is solving, because, I think like most noble Lords, I have no idea why this provision is in the Bill and what it is trying to solve.

The noble Baroness, Lady Coffey, rightly asks in her amendment for us to think of patients rather than the organisation. The noble Lord, Lord Kamall, goes further, and I find his approach the most persuasive in the group. It is that, basically, a change would have to be necessary to improve patient outcomes. Surely that is the test against ideology from either a public or a private direction. The Secretary of State would also publish the reasons and lay them before Parliament.

The amendments from the noble Baroness, Lady Bennett, raise serious concerns in terms of completely undermining what a public health service—the NHS—should be about. It should be about quality, about outcomes and about patients having choice. The Secretary of State should not dictate which type of hospital a patient should go to, as long as the basis is free at point of use, the quality of care is monitored, and outcomes are the same as in a publicly funded body. I really look forward to the Minister explaining the reason for Clause 10, because I believe that most noble Lords would like to understand exactly what problem it is trying to solve.

Lord Kamall Portrait Lord Kamall (Con)
- View Speech - Hansard - - - Excerpts

My Lords, I am grateful to all noble Lords who have spoken on this group of amendments. Let me begin by speaking to the amendment in my name and that of my noble friend Lord Howe and to the clause stand part notice in our names as well as those of the noble Lords, Lord Hunt of Kings Heath and Lord Patel of Bradford.

This group of amendments seeks to query the future provision of NHS services and, in particular, the principles that should govern decisions about the balance between state or taxpayer-funded and independent providers. There is a straightforward principle here: decisions about healthcare and the provision of healthcare should be guided, as the noble Lord, Lord Scriven, said, by what is best for patients rather than by some predetermined preference for one type of provider over another. This should not be about ideology; it should be about the interests of individual patients.

We know that the NHS seeks to serve patients. Its success should therefore be measured not by organisational arrangements or ownership but by the quality, accessibility and timeliness of care, and how it improves the health and well-being of patients. As such, Amendment 35 seeks to give effect to that principle by ensuring that any variation in the balance between publicly and independently provided health services is undertaken only where the Secretary of State is satisfied that it is necessary to improve patient outcomes.

That is important because, as it stands, Clause 10 permits the Secretary of State to dictate that balance in what they consider to be

“the interests of the health service”.

Sadly, as we know, the interests of the health service are not always the same as the interests of patients. The focus must remain on the best possible patient outcomes, but the interests of the health service might be interpreted in terms of organisational priorities or administrative convenience. Can the Minister explain why the Government have not created a specific duty for the Secretary of State to justify decisions in terms of patient outcomes? Does she accept that

“the interests of the health service”

may be seen as too broad?

--- Later in debate ---
Baroness Merron Portrait Baroness Merron (Lab)
- Hansard - - - Excerpts

At the risk of repeating myself, as I have said, the judgment is about acting reasonably and rationally and about whether it was fulfilling its duty. It would also be—I know that I am repeating myself, but it bears doing so—accountable to Parliament for its decision.

The noble Lord, Lord Patel of Bradford, raised a question—

Lord Scriven Portrait Lord Scriven (LD)
- Hansard - -

If the Secretary of State was acting under Clause 11 powers, Parliament would not have knowledge of that or any say on it. Does the Minister agree that that would be a correct interpretation of Clause 11 being used to bring about a change in public/private provision in Clause 10?

Baroness Merron Portrait Baroness Merron (Lab)
- Hansard - - - Excerpts

I am not sure that I can answer that right now, but I will certainly review the various clauses and come back on that point.

The noble Lord, Lord Patel of Bradford, raised a point about publishing reasons where an exception is made. I will look at that because, as he knows, we are very much committed to transparency.

I turn to the amendments from the noble Baroness, Lady Coffey, the noble Lord, Lord Kamall, and the noble Earl, Lord Howe, which I will discuss together. The phrase

“the interests of the health service”

reflects the Section 1 duty to the health of all people in England—both those currently using the NHS and those who might want to use it in the future. That said, I understand the points noble Lords are making and, as with all things, I will certainly look at them. But we believe that substituting the phrase so that the test may be used in the interests only of patients, as spoken to by the noble Lord, Lord Kamall, is a narrower approach that risks excluding the potential benefits to the service over time, and it excludes the interests of people who are not currently patients—which I know is not the noble Lord’s intention.

I would also caution against using an additional requirement that exceptional action must be

“necessary to improve patient outcomes”.

This might prevent the rescue of a failing service, given that it relates to improving, and not stabilising, services. For example, if a dialysis provider serving a large area failed, stepping in would clearly be necessary to keep treatment going, before any action to improve it. It therefore risks failing the proposed test at a time when decisive action is needed.

--- Later in debate ---
Lord Scriven Portrait Lord Scriven (LD)
- Hansard - -

Just to be helpful, will the Minister write to the Committee before Report explaining the reason for Clause 10? I am not sure whether other noble Lords were in the same position as I was, but I did not understand and was not convinced as to why it was required, even after the Minister explained. Could she give real, practical examples of why the clause is required, based on the 2006 Act not allowing the Secretary of State the powers to make the provision between private and public that is required to improve patient care in a particular area? That would be helpful, I feel.

Baroness Merron Portrait Baroness Merron (Lab)
- Hansard - - - Excerpts

I will be pleased to write further on the comments that I made.

Baroness Bennett of Manor Castle Portrait Baroness Bennett of Manor Castle (GP)
- View Speech - Hansard - - - Excerpts

My Lords, I thank all noble Lords who have taken part in this fascinating and important debate, and I thank the Minister for her response.

The noble Baroness, Lady Coffey, said she thought I would be alone in my views, but we have heard from different quarters around your Lordships’ House expressions of concern about the destructive impact of markets and tendering on the NHS; the noble Lord, Lord Hunt, said so in his speech, and indeed he is nodding now. There is good evidence that the views of your Lordships’ House do not reflect the views of the public. I point noble Lords particularly to a study in Social Theory & Health in 2022, which I believe is the only time there has been an open-ended, representative survey of UK citizens about their view of privatisation. Lots of basic questions have been asked, such as “Do you think privatisation is a bad thing?”, but I think that is the only time the question has been asked: why do people think that? The largest single reason was the extraction of profits from NHS services. There is strong public resistance to that, and noble Lords should bear that in mind. The public see clearly that money that should be going to services is going to profits instead, and that is what my group of amendments seeks to address.

We have Committee stage for a reason, to probe amendments, and many noble Lords have probed at mine. To reassure the noble Baroness, Lady Thornton, and others, I certainly need to look at the wording of this. When I was talking about public and private, by “private” I was referring to for-profit providers. I reassure the noble Lord, Lord Scriven, and others that there is no intention here to do away with hospice provision, charity provision and not-for-profit provision. These amendments are all aimed at the for-profit sector.

Lord Scriven Portrait Lord Scriven (LD)
- View Speech - Hansard - -

So if the partners at a GP practice made a surplus or a profit at the end of the year, would they fall under the definition that the noble Baroness has just given?

Baroness Bennett of Manor Castle Portrait Baroness Bennett of Manor Castle (GP)
- Hansard - - - Excerpts

There is a particular issue with GP practices. My position is that I do not think there should be for-profit in healthcare. That is my long-term position.

--- Later in debate ---
Baroness Thornton Portrait Baroness Thornton (Lab)
- View Speech - Hansard - - - Excerpts

My Lords, I will make one or two remarks and probably ask some questions of the supporters of Amendment 180. I regard these amendments as what one might call the “moving parts” amendments. We are all trying to work out how on earth we are going to get reform in the NHS and get social care and all those things, which is why the questions from the noble Baroness, Lady Watkins, were particularly pertinent. It is reasonable that, during the course of the Bill, we should be asking how social care is going to be pushed forward and whether we need to put measures in the Bill which will help that process, even though we know we are in the middle of the Casey review and we have the determination of our Prime Minister to deliver long-term change to our social care system.

There are two questions I want to ask the noble Lord, Lord Kamall. Why does Amendment 180 exist without any reference to what is happening at the moment, which is that we are in the middle of a social care review that will bring forward some proposals about what a national care service should look like? Also, perhaps the noble Lord would like to talk a little bit about the commitment that his party will make to that social care reform and the need for there to be consensus and cross-party review to take it forward. In that way, I kind of welcome what the amendment says, but I am slightly puzzled as to why it sits there in the Bill and does not really relate to what is actually taking place.

Lord Scriven Portrait Lord Scriven (LD)
- View Speech - Hansard - -

My Lords, these amendments seem small but they are slightly the elephant in the room in terms of dealing with real people who have complex needs, and who do not fall into administrative boxes called “health” and “social care”. They have needs that sometimes cross both care and the NHS.

At Second Reading, a noble Lord—I cannot remember who—said that the problem with this Bill is that it is not really a Health Bill; it is an NHS Bill. It is about the structures and how the NHS works. It is a bit more complex than saying there are two potential things—a Bill and a review—going on. There is the social care review, from which we expect the national care service, and possibly legislation will be required for that. There is this Bill going through Parliament. Yet there is also the context of rewiring the state, which will have a significant impact on health and social care, and therefore how services are commissioned and provided.

I ask the Minister a simple question: how do all three fit together? Do she and the Government foresee any changes to provisions in the Bill once those two other pieces—the review and the legislation—go through about how funding, commissioning and services will be provided to people who require health and social care?

Baroness Pitkeathley Portrait Baroness Pitkeathley (Lab)
- View Speech - Hansard - - - Excerpts

My Lords, I support Amendments 42 and 44, because—as others said—they are the nub of a lot of the stuff we are having to think about in the Bill. They are an attempt to change the status of social care, from being the Cinderella, the tail-end Charlie, always the bridesmaid, or the poor relation. How many times have we referred to social care in those terms? We know that the system is not fit for purpose. We know that local authorities in a very few years will not have any money even for waste collection because social care will take such a huge percentage of their budgets. Even now, local authorities provide services only for those with needs classed as severe or critical.

When people cannot get social care services, what do they do? Of course, they turn to the NHS, resulting in pressure on services, delayed discharges and shortages—in a service that is already under severe pressure. Cost-cutting is then put ahead of patient welfare, and hospitals themselves are not meeting the required standards and do not have enough staff on duty to care properly for patients. Time and again, we find that social care, properly delivered, of good, reliable quality and with an emphasis on prevention, is a better way of caring for frail, elderly or disabled people than healthcare—and much better than an expensive hospital bed could ever provide that kind of care.

What is needed is integration. Now, I have never heard anybody say anything other than that health and social care should be integrated. I have been working on this for 40 years and everybody always says, “Oh yes, we must integrate”. Yet as far as getting under way with that is concerned, we have not done very well, because we have not really done anything about readmission rates when people are discharged. As soon as a person comes into hospital, it should be a priority to ensure that they do not stay in hospital longer than they have to, by having discharge procedures which provide a seamless transition and making sure that the all too frequent readmission because of inadequate integration between health and social care is guarded against. In this sense, the Government’s plans for a national care service are very much to be welcomed—this will be discussed in a later group of amendments—particularly their emphasis on raising the status of those who work in social care so that they are not seen as inadequate partners of those working in healthcare.

--- Later in debate ---
Baroness Merron Portrait Baroness Merron (Lab)
- View Speech - Hansard - - - Excerpts

My Lords, I am most grateful to noble Lords for bringing the important matter of social care before the Committee. I am sure that the noble Lord, Lord Kamall, knows that, as much as I would love to give him every dot and comma, there is a reason why that is not possible.

Amendments 42 and 44, tabled by the noble Baroness, Lady Tyler of Enfield, and spoken to by the noble Baroness, Lady Pidgeon, my noble friend Lady Pitkeathley and the noble Lord, Lord Scriven, relate to the Secretary of State’s role in respect of social care. I think we could not have been clearer—we have discussed the role of the Prime Minister today—about the strength of national leadership that is required. The noble Baroness, Lady Pidgeon, acknowledged that the Prime Minister committed to establishing a national care service in the next Parliament to sit alongside our National Health Service and to be linked with it.

On the matter of the amendments, the reality is—at the risk of sounding simply pragmatic in legislative terms, but I will take that risk—that adult social care already has its own statutory framework under the Care Act 2014, which is separate to this legislation. That Act provides legal duties on local authorities for the provision of care and support in England and gives the Secretary of State overarching supervisory and intervention responsibilities.

As we develop our plans for national care services, that is where we will consider the responsibilities, the accountabilities and where they will operate—to refer to some of the questions that the noble Lord, Lord Scriven, raised. As I have indicated, although they are linked, health and adult social care have distinct roles—complementary, yes, but distinct—and each is crucial in its own right to providing care for our citizens, as the noble Baroness, Lady Barker, described.

As plans for reform develop—I will come back to the point about the noble Baroness, Lady Casey—we will work with partners and stakeholders to consider how we can do exactly what noble Lords are rightly asking for: consider how accountability, funding flows and responsibilities can be clear and more consistent. But my noble friend Lady Thornton described this as a Bill of moving parts, which was a good description. On the basis that we are talking about moving parts, nailing down one before all the relevant parts have been dealt with will get us into more difficulty. Frustrating it may be, but that is the honest reality.

Lord Scriven Portrait Lord Scriven (LD)
- Hansard - -

Following that logic, why are we nailing this part down before the others are ready?

Baroness Merron Portrait Baroness Merron (Lab)
- Hansard - - - Excerpts

The reason is that we consider that these parts can sit on their own, and the Bill allows us to look forward too. It would not be acceptable—the noble Lord is not suggesting this—if we stopped all our work while we waited until everything was in place. Although my noble friend is right, I cannot really remember a time when we did not have a lot moving parts—or perhaps we had some parts that should have been moving more but were not, to be more precise.

I go back to the commission on adult social care of the noble Baroness, Lady Casey, about which the noble Lord, Lord Kamall, asked further questions. First, its work has already been brought forward by a year by Prime Minister Andy Burnham. We have already actioned the initial recommendations. As a reminder, we worked at pace on that and I emphasise that the review is independent, which by definition means that we are allowing the noble Baroness, Lady Casey, to do her work.

The other point, which has been absent in previous iterations of attempts at this work, is that we are committed to making this an all-party answer that can survive Governments. All Governments previously have failed to do that, and this is too big and too important an issue to fail to secure that backing. The early recommendations that we put straight into place were—oh, I see the noble Lord standing up; I thank him for being very specific.

--- Later in debate ---
We cannot promise to bring back the family doctor while organising the NHS in ways that makes it even harder for doctors to know their patients, and vice versa. Continuity is not a luxury; it is fundamental to good medicine. We know it works. This amendment is an opportunity to ensure that, as the NHS changes, continuity is protected rather than lost by default.
Lord Scriven Portrait Lord Scriven (LD)
- View Speech - Hansard - -

My Lords, I feel like a mere iron filing after the magnet of wisdom and knowledge from the noble Baroness, Lady Gerada, on primary care and continuity of care, but I will be a little iron filing that does its best. I will speak to Amendment 60, which would insert a new clause after Clause 14, and Amendment 62 to Schedule 1. They are both in my name and I thank the noble Lord, Lord Holmes of Richmond, who is not in his place at the moment, for adding his name to them.

These amendments are about people who the NHS too often fails to see and who, too often, cannot see well for themselves. SeeAbility has campaigned on this for many years and I am particularly grateful to Scott Watkin and Donna O’Brien for their help, research and guidance on these amendments. Research for the Royal National Institute of Blind People and SeeAbility found that adults with a learning disability are 10 times more likely than the general population to be blind or partially sighted. Nearly one in 10 is blind or partially sighted and around six in 10 need glasses. For children with a learning disability, the risk of serious sight problems is 20 times higher.

The conditions are cataracts, glaucoma, diabetic retinopathy and keratoconus. The last of those conditions affects as many as one in 10 people with Down syndrome. According to the Down’s Syndrome Association, if it is not caught early it can take sight for good, yet those at greatest risk are among the least likely to be tested. Around half of adults with a learning disability have not had a sight test in the recommended two years.

When SeeAbility tested children in special schools, more than four in 10 had never had their eyes checked at all. Many people with a learning disability cannot tell us that their sight is failing; instead, it shows up as withdrawal, distress or falls, and too often this is put down to the learning disability itself. This is called “diagnostic overshadowing”: people labelled as challenging when the real problem was that they could not see.

When an adopted pathway was piloted in three London boroughs, over half of those tested had an eye problem that could lead to sight loss, and nearly two-thirds ended up in glasses. Amendment 60 would change Regulation 3 of the Primary Ophthalmic Services Regulations 2008, which lists who gets free NHS sight tests: children, people over 60—probably including many noble Lords—people with diabetes or glaucoma, and people over 40 with a family history of glaucoma. The logic is clinical risk. By that logic, people with a learning disability should be on the list. Today, an adult with a learning disability, however profound, gets a free eye test only by qualifying some other way, often through a means-tested benefit.

So my first question to the Minister is: what is the clinical justification for giving a free eye test to somebody over 40 with a family history of glaucoma but not an adult with a learning disability, who is 10 times more likely to go blind or be partially sighted? The amendment deliberately covers people eligible for the GP learning disability register, not those already on it. The registers undercount, and no one should be denied a test because a practice has not updated its list. It also links to the annual health check, where GPs can prompt for that eye test.

There is also a data problem. NHS sight test claim forms have not recorded disability, so we cannot know how many people with a learning disability get a test. Can the Minister confirm whether that data is now recorded and, if not, how the department can say it is reducing an inequality when it does not measure it? Will it add this field to the data collection?

Amendment 62 deals with assessing need and commissioning services, because a free test is necessary but not enough. The NHS sight test fee is £24.13, and the Association of Optometrists estimates that it covers only about half the cost of a standard test. It pays nothing towards the longer appointments or Easy Read results that many people with a learning disability need. Many are sent to overstretched eye hospital services that are not appropriate to their presenting need. The Easy Eye care pathway, with longer appointments from specially trained optometrists, works, but it is commissioned only in south-east London, parts of the north-west and Durham. Everywhere else, the system is literally blind to the need. Can the Minister say what the plans are to try to ensure that every integrated care board now commissions this type of test? What will the Government do to ensure that it becomes standard across England?

This Bill moves NHS functions, including primary ophthalmic services, to the Secretary of State. This amendment would require the Secretary of State to assess the need and to direct ICBs—I know what I have said previously, but it is still in the Bill—to improve and measure the eye health of people with a learning disability through targeted action. As I said, I am wary of open-ended powers of direction, but I have argued that the Secretary of State should set clear outcomes and hold the system to them. This is exactly the kind of outcome that I would like.

I give the Government credit: the Special Schools Eye Care Service has £12.7 million of recurrent funding to reach up to 165,000 children. However, schools must opt in, rollout is uneven and, at 19, these young people fall off the cliff edge into an adult system not built for them. Will the Minister confirm by what date the service will be available to every ICB in England and what will happen to those young people’s eyecare when they leave school?

The NHS rightly recognises that people with diabetes need regular eye checks because they are at higher risk. People with a learning disability are at much higher risk and far less able to tell us when something is wrong. These amendments would bring them into line with the clinical risk profile that they face with their eyes. No one should lose their eyesight because the system was not designed with them in mind. I hope the Minister will look favourably at these amendments and I look forward to her response.

Baroness Finlay of Llandaff Portrait Baroness Finlay of Llandaff (CB)
- View Speech - Hansard - - - Excerpts

My Lords, I thank the noble Baroness, Lady Neville-Rolfe, for having brought this to our attention. As my noble friend Lady Gerada said, continuity of care is incredibly important. A relationship with a clinician is a two-way process. As a patient, you need to have confidence in that clinician and they need to understand the complexity of you as a person. It is very easy to think that this is all about facts that we write down: observations and things that go in patient notes. However, it is important to remember that about 80% of communication is non-verbal. Therefore, the way that you have seen a patient and the way that you observe them later on become absolutely critical.

In my own time when I was a GP, we used to take all our own calls up until midnight and then quite often we were in the pooled rota with other practices. However, that meant that whoever phoned up during the evening was somebody we already knew and understood, and I think we were able to give much more appropriate advice or decide to go straight out to see them than happens now with the 111 screening process.

In my own discipline of specialist palliative care, that continuity is incredibly important. We are looking after patients with very complex needs, often very young people, and conversations with children about the fact that their parent is dying is not something that you can have from one person to another. It has to be the same clinician, whether that is a specialist nurse, the doctor or a specialist social worker, who then follows through. Building up confidence with that family as they face the ultimate disaster is really important, and most of that is non-verbal and interpersonal.

We have seen the advent of Martha’s rule, which has come about because parents have observed that their child was looking and behaving less well, and they were alert even though the staff around had not noticed or picked up on the signs. In a terribly sad way, that is an overwhelming testament to the importance of some continuity, rather than simply looking at observations and exchanging facts.

I can see that perhaps the wording of the amendment could do with a little modification. However, we have raised a very important subject tonight and there is a core principle, and that will mean stripping out some of the bureaucracy that is stopping clinicians from having the continuity that they want to have and that their patients want from them.

The noble Baroness, Lady Neville-Rolfe, spoke about patients getting letters. In fact, it is now standard practice across the NHS in secondary care that a patient will get a letter. Sometimes it is dictated at the time when the patient is still in the room and then they will get the hard copy afterwards. Some clinicians will tape-record the conversation—although not so much now—and allow the patient to listen to it again at home later on, and then see them for questions to be asked. That has come about, but it does not substitute for this core principle of actually being able to have continuity. The one thing that is important is that we do not force patients to be locked into continuity with somebody who they do not feel comfortable with or have confidence in, and who, really, they never want to see again. They need to be able to choose to see somebody different.

Baroness Coffey Portrait Baroness Coffey (Con)
- View Speech - Hansard - - - Excerpts

My Lords, I appreciate that continuity of care is seen to be the holy grail of what will make our country safer and healthier. There is some merit to having that understanding of what is happening in somebody’s life and what they have been through. However, I would hope that the single patient record can go a long way to understanding that.

I notice that the noble Baroness, Lady Gerada, is shaking her head in a negative way rather than in a positive way. I feel differently because when I am ill, I just want to be sure that I can see a doctor. The amendment tabled by the noble Baroness, Lady Pidgeon, talks about a seven-day guarantee to see a GP. That is potentially unrealistic in terms of some of the broader issues that people might want to see their GP about.

A few years ago, I set a target of 14 days. I got criticised at the time. There are those people who feel a lump or that something is not quite right, but it is not urgent. They do not go to their GP very often, perhaps only every five years, but they should feel that they can get something that does not feel right looked at. The seven days is admirable, but I am trying to imagine what it would be like. I appreciate that, among all noble Lords in the Chamber tonight, the noble Baroness, Lady Gerada, with her experience of the Hurley Clinic and others, recognises the day-to-day challenges that GPs experience in managing a significant practice.

I am very sad that the noble Baroness, Lady Janke, is not here—

Lord Scriven Portrait Lord Scriven (LD)
- Hansard - -

My noble friend Lady Janke is here and in her place.

Baroness Coffey Portrait Baroness Coffey (Con)
- Hansard - - - Excerpts

I apologise. I could see the head of the noble Lord, Lord Scriven, but not beyond it. I look forward to hearing what the noble Baroness has to say about pharmacies.

I intend to table some amendments to Clause 42 to understand the issue that the noble Baroness, Lady Janke, is going to raise. It may be that she has a particular experience. In my experience of pharmacies, I have not experienced a situation where a pharmacy provider has fallen apart unnecessarily. However, I have noticed a trend in more than one part of the country of GPs having done the traditional thing of the partnership buying a property, which they then sell. They then have a property for which they pay rent. They bring in a national pharmacy provider which will pay them rent. The independent pharmacist on the high street or nearby starts to fall apart because the natural tendency with these shiny new practices is that the sale of the old one has released capital but that rent needs to be paid. As a consequence, any subsidy to that from other willing providers is very welcome.

I am looking forward to hearing the issues but give fair notice to the Minister that I intend to return to Clause 42 in due course. I just have not had time to table the amendments.

Baroness Merron Portrait Baroness Merron (Lab)
- Hansard - - - Excerpts

I would be very happy to do that.

Lord Scriven Portrait Lord Scriven (LD)
- Hansard - -

I have been listening very carefully and, in answer to my noble friend, the Minister has just said that secondary legislation will be for all NHS services by choice. What stops that being put on the face of the Bill?

Baroness Merron Portrait Baroness Merron (Lab)
- Hansard - - - Excerpts

This is the point I have just raised: we feel that secondary legislation is the better place to put it for flexibility and future-proofing; it is not appropriate, in a static way, for primary legislation.

Lord Scriven Portrait Lord Scriven (LD)
- Hansard - -

As I am sure the Minister agrees, that would make sense if you were putting the operational services down. If you were making a commitment in Clause 5 that all NHS services in secondary, primary and community services will be accessible for choice, it would then give discretion within that boundary. I do not understand what stops the Government putting those principles on the face of the Bill, rather than making the operational amendments, which the Minister said were too restrictive.

Baroness Merron Portrait Baroness Merron (Lab)
- Hansard - - - Excerpts

I think we just have a difference of approach to and opinion about the roles of primary and secondary legislation. I respect what the noble Lord is saying and I will of course review the points that have been made, as I always do; however, the position is exactly as I have described.

--- Later in debate ---
Lord Kamall Portrait Lord Kamall (Con)
- Hansard - - - Excerpts

My Lords, let me make it clear that I recognise that what I am asking for does not need to be in the Bill and does not need legislation. However, my frustration at the lack of progress, both when I was the relevant Minister and as shadow Minister, has forced me to table this probing amendment.

I often meet entrepreneurs and tech companies who claim that they have an innovative product or solution that could transform healthcare. They ask me how they can have a conversation with the relevant person within the NHS. When I was a Minister and I asked my officials about this, they would give me an email address I could share. However, two things stayed with me. First, why was this email address not widely advertised and known by more people? Secondly, when I asked such entrepreneurs whether anyone from DHSC or NHS England had replied, the answer was no.

In opposition, I began thinking, “How can I help more innovators into the NHS?” It was suggested that I meet the Health Innovation Network, which told me that it is the front door for innovation. However, once again, many tech entrepreneurs have never heard of it. I was surprised to read on the Health Innovation Network’s LinkedIn page that it has “501-1K employees”. How about that for precision? Speaking to noble Lords and others interested in health innovation, I have heard a range of opinions about the local networks—that some are good, some are bad and some are in the middle. While some regional health innovation networks are good, others are not so good and coverage is patchy. This brings me to my question. What is the Health Innovation Network’s remit, and what assessment have the Government made of local networks’ effectiveness? What plans do the Government have for the networks in the reorganisation?

I recognise that there is a fantastic clinical entrepreneurs programme led by Tony Young, an NHS surgeon and clinical entrepreneur. He has always been very open and has encouraged me to send on to him clinical entrepreneurs who have approached me, in order to have further conversations. The question relating to this amendment is: what about entrepreneurs who are not clinicians, but who have an innovative solution that could transform health or social care? For them, there is no obvious front door to the NHS or one-stop shop. What do they do? They spend ages trying to get into the system at primary care, trust or ICB level, sometimes wasting their time but also clinicians’ precious time. Sadly, they then give up or go abroad, meaning that the UK loses out on British innovation.

In July, during an Oral Question, I asked the Minister to ask the DHSC Minister for technology and innovation to create such a front door or one-stop shop to triage those who approach it. That front door could distinguish those salespeople who have no minimum viable product, telling them what they need to come back with to be taken seriously. Secondly, what about those who have a solution but need more support, so that they can be signposted to someone who can advise them on coming up with a more feasible approach? Thirdly, there are those who have potentially a fantastic solution that could transform healthcare and need to be piloted as quickly as possible.

I was grateful when noble Lords from all Benches later told me that they agreed that this was a practical idea. Has any progress been made since I asked that question in July. If not, what are the reasons why? Time and again I hear the same concerns from entrepreneurs, researchers and businesses: the system is difficult to navigate, and numerous organisations are involved in supporting innovation, all with different remits, processes and points of entry. Expertise clearly exists throughout the system, but identifying the right door to knock on can be a challenge in itself.

This amendment seeks to address that problem through a simple but important principle: that there should be a single national point of access through which innovators and other organisations can obtain co-ordinated support. The purpose is not to create another bureaucratic layer; on the contrary, it is intended to reduce complexity, improve co-ordination and ensure that innovators spend less time navigating the system and more time developing solutions that could benefit patients. The principle behind the amendments mirrors one that the Government have embraced elsewhere in the health service. The concept of a single point of access, or a single front door, is designed to simplify routes into services, triage inquiries effectively and direct people to the most appropriate expertise at the earliest opportunity. Rather than forcing patients to navigate multiple pathways, the system assumes responsibility for guiding them to the right destination.

My Amendment 27 applies precisely that same logic to innovation. Instead of requiring innovators to work their way through a maze of organisations and programmes, a single front door would provide a clear route into the system, supported by intelligent triage to the most appropriate person in the Department of Health and Social Care or the NHS. It could be, but not necessarily, one of the 501 to 1,000 people who work for the Health Innovation Network. I beg to move the amendment.

Lord Scriven Portrait Lord Scriven (LD)
- View Speech - Hansard - -

My Lords, I thank the noble Lord, Lord Kamall, for moving this amendment and for the very short debate that has followed. I believe that the frustration is real, but the Committee deserves answers to two questions: what is in place now and would the proposed new clause make it better?

As the noble Lord, Lord Kamall, said, there are 15 health innovation networks, each serving its own region, but there is already a national point of access. The NHS Innovation Service, as the noble Lord, Lord Kamall, said, has been running since 2022, when it was set up by a very forward-thinking junior Health Minister—the noble Lord, Lord Kamall. NHS England describes it as a single entry point. An innovator completes one record. Experts from within the network review it within 10 working days, give tailored advice and can refer the innovator to one or more local networks. More than 2,000 innovations have had support through that service.

Proposed new paragraphs (a) and (b) of proposed new subsection (2) in this amendment largely describe something that already exists. Does it work? As a front door, it appears to do so in some regions for some people. The problem is that if the amendment from the noble Lord, Lord Kamall, was accepted, it would create two front doors for people to come through, which would probably not be a wise thing to do.

I believe that the front door is not the main problem here; the problem is spread. Adoption is one trust taking up a good idea; spread is that everything gets to the patient, no matter where they live. The Health Innovation Network’s own evidence to Parliament says adoption is

“slow, uneven and overly dependent on local early adopters”.

It describes what it calls

“a postcode pattern of spread”,

and warns that

“proven technologies do not spread through evidence alone”.

An innovation proven in one place can face the same hurdles all over again in the next, so I do not believe that we have a front door problem.

Therefore, I must be honest. As drafted, this proposed new clause would help only at the margins and it could hinder. It could create a second door beside the one we have, unless it simply puts a statutory label on the existing service. It would write an operational arrangement into primary legislation, when the way innovators are supported should be one that changes quickly. It would place duties around networks that neither the Bill nor the proposed new clause define.

There are two parts that I welcome. Proposed new subsection (3) would require published information on performance, and we should be told how many innovations spread beyond their first site and how far. Proposed new subsection (2)(c), on co-ordinated support across regions, goes closer to the real issue, but the network says that spread needs systems with

“the resource to redesign pathways, train staff and evaluate impact in practice”.

A referral service does not provide that.

The amendment’s most important contribution is the question it raises. NHS England runs the innovation service. The network’s national commission comes from NHS England, with the Office for Life Sciences. However, the Bill abolishes NHS England. Clause 6 gives the Secretary of State a duty to promote innovation and a power to award prizes, but it says nothing about the networks. A prize will not help a company stuck between a successful pilot and its second trust.

I have a few questions for the Minister. Who will run and fund the innovation service, and commission the networks, once NHS England has gone? Can she guarantee that there will be no gap? Will the Government publish performance data, including on adoption and spread, which is lacking, whether this amendment is accepted or not? Who, after abolition, will be responsible for making sure that proven innovation spreads across the whole NHS, not just to the early adopters?

A single door is a reasonable aim and we largely have one. What patients need is for it to work in one part of the NHS and then to reach all of it. I look forward to the Minister’s reply.

--- Later in debate ---
Lord Kakkar Portrait Lord Kakkar (CB)
- View Speech - Hansard - - - Excerpts

My Lords, I support the amendment in the name of the noble Baroness, Lady Shawcross-Wolfson. It is an important amendment raising two fundamental questions, which I hope the Minister will be able to answer. The first is this: ultimately, in preparing a workforce plan that will enjoy broad confidence, there must be external scrutiny of that plan. It would be most helpful if the Minister could confirm how His Majesty’s Government’s healthcare workforce plan will be independently scrutinised. Also, how will His Majesty’s Government be able to reconcile potential differences generated as part of that independent scrutiny with what they consider to be deliverable at this particular moment in time?

The second issue is how a mechanism will be secured—now that the functions independently exercised in NHS England will become the responsibility of the Secretary of State for Health—in respect of long-term workforce needs and short-term financial pressures. As we have heard, investment in the workforce is a long-term investment, and Ministers will always be faced with short-term financial problems and crises. Historically in the NHS, the education and training budget has been periodically sacrificed when there have been other service, access and delivery demands on NHS institutions.

In providing an opportunity now with this Bill, how will the Government address that fundamental tension and secure a mechanism both for independent scrutiny and to ensure—with all the powers now lying in the hands of the Secretary of State for Health—that the education and training budget that secures the long-term development of the workforce cannot be sacrificed for short-term exigencies?

Lord Scriven Portrait Lord Scriven (LD)
- View Speech - Hansard - -

My Lords, I will speak mainly to Amendment 252 in the name of the noble Baroness, Lady Hollins. I apologise for not putting my name to it; I wish I had.

But I wish to speak first on two other amendments. The amendment from the noble Baroness, Lady Shawcross-Wolfson, is useful, and I thank her for the way that she presented it. An independently verified assessment and a 10-year plan is exactly what is needed. But I do have a word of caution. Publication within one month of Royal Assent could be a real challenge, even considering the amount of time that we have been waiting. Also, a plan that is produced that quickly risks being inaccurate, and an inaccurate workforce plan is worse than none at all, because people will make training and funding decisions on it. The amendment from my noble friend Lady Pidgeon offers a better timescale of 12 months from Royal Assent as well as an assessment of the staff needed, a funded plan to close the gap and an annual report to Parliament.

Amendment 252 matters because it names people who are easily forgotten in workforce planning: that is, the staff who care for people with a learning disability. Let me start with why that matters. The latest—in fact the last ever—national LeDeR report found that the median age at death for adults with a learning disability was 62.8 years, compared with 81.8 years for the general population. That is a gap of 19 years. Many noble Lords will know that my own wonderful nephew, Myles, who was 31 years old, is part of that terrible, tragic statistic. Some 39% of deaths of these adults were judged to be avoidable, against 21% for the general population. No workforce plan can fix that alone, but no plan that ignores it is worth having.

Lord Scriven Portrait Lord Scriven (LD)
- View Speech - Hansard - -

My Lords, I just have a very quick practical suggestion to deal with some of the issues the noble Lord, Lord Blencathra, and others raised about staff neutrality, because that is what we are talking about. Would it not be wise, rather than going through a long process, to make it part of the NHS constitution that staff have to be neutral in how they deal with fellow staff and patients with whom they come into contact? I ask the Minister to consider that seriously when she reports back not just today but on Report. It is just a practical suggestion.

Baroness Finlay of Llandaff Portrait Baroness Finlay of Llandaff (CB)
- View Speech - Hansard - - - Excerpts

I will be very brief in supporting that suggestion from the noble Lord, Lord Scriven. When I was listening to the debate, I was thinking about people who have told me about feeling discriminated against. They often do not declare their racial, religious or whatever view, because they are terrified of being further labelled and discriminated against. The noble Lord, Lord Shinkwin, spoke about the history of this for the Jewish people; there were lists of who was Jewish, particularly in the Netherlands, which were rapidly exploited to round them up with speed and persecute them further. That is a very deep-seated fear in a lot of these people.

The other fear is that, if they disclose that they have been discriminated against, they will be undermined in other forms that make their lives even harder. I can again think of other specific examples that have been brought to my attention. I commend this solution as a way forward.

--- Later in debate ---
I thank the noble Lord, Lord Scriven, for raising consideration of staff neutrality, as was also spoken to by the noble Baronesses, Lady Finlay, Lady Pidgeon and Lady Cash. We are clear that staff must demonstrate the core values of the NHS and demonstrate neutrality in the workplace. I would go further. I do not know that I would use “neutrality”; it is an issue of fairness, and “without fear or favour” might be the other expression.
Lord Scriven Portrait Lord Scriven (LD)
- Hansard - -

My point about the important value of neutrality is this, and let me give an example. You might not be discriminatory: you have somebody who is Jewish, somebody who is Muslim, somebody who is Christian and somebody of no faith, and you treat them all equally, but you might have something on your body which is not neutral to two of them. You are therefore possibly treating that person differently, from their perspective. If neutrality and fairness is such an important value for the NHS, can the Minister go away and look seriously at making it a key component in the NHS constitution, because it is not there at the moment?

Baroness Merron Portrait Baroness Merron (Lab)
- Hansard - - - Excerpts

I take that point and I certainly accept the spirit in which the noble Lord suggests it. I will take all the points that have been discussed away to see whether there is any way that we can work with it, rather than extending a debate on what neutrality means, because I know what the noble Lord is getting at. It is helpful that he has given thought to that.

On Amendment 258, NHS bodies are already subject to clear legal duties to prevent and address discrimination and racial harassment, alongside established responsibilities to tackle extremism and safeguard patients and staff. In a technical fashion, I certainly caution against adding further legal duties here because it would risk confusion about what we expect ICBs and trusts to do. I know that is not something that any of us would wish to do.

On Amendment 259, we have accepted the recommendation from the noble Lord, Lord Mann, to consider amending the performers lists regulations, which would enable conditions to be imposed on suitability grounds. We intend to amend the regulations, subject to consultation. The amendment is unnecessary as the Government are already taking forward the substance of it. It would also impose a six-month statutory deadline before the necessary consultation and consideration have taken place, whereas we have to allow sufficient time to make sure that any changes are legally robust, proportionate and workable. Nor would we wish to pre-empt consultation by committing in this moment to how particular forms of conduct should be addressed in the regulations.

On Amendment 279C, under NHS staff standards—which, as I referred to on the comments from the noble Baroness, Lady Manzoor, were launched on 6 July—employers must take sustained and meaningful action to prevent and root out racism. NHS organisations will be measured on this through the national oversight framework. In addition, I say to the noble Lord, Lord Blencathra, that regulatory processes are already in place to which all registered healthcare professionals are subject. Regulatory fitness to practise processes allow concerns about misconduct to be investigated. They allow evidence to be considered and the appropriate regulatory action, which could indeed include removal from the register, to be determined in each case. The Professional Standards Authority for Health and Social Care acts as an independent body in this regard to make sure that regulators apply the right sanctions. Where it considers that a decision does not provide sufficient public protection, it has the powers to refer the decision to the courts for consideration.

In drawing this together, I assure the noble Baroness, Lady Gerada, the noble Lord, Lord Patel of Bradford, and your Lordships’ Committee that we are ensuring that ICBs and providers are fulfilling their duties. The key means to do that is through performance assessments. I gently caution against adding additional criteria to the current approach, because it is important that assessments have sufficient flexibility to adapt to the evolving role of ICBs as strategic commissioners, which, after all, is at the heart of the Bill.

We have fantastic staff in these lovely hospitals where we have been treated, but they are given a management that I do not think often works. This is the opportunity we have to grasp. We have to deal with it and not be the sort of people who are always very difficult and behave like turkeys that do not want Christmas to come.
Lord Scriven Portrait Lord Scriven (LD)
- View Speech - Hansard - -

My Lords, I thank noble Lords who have spoken in this rather revealing debate. I particularly thank the noble Earl, Lord Howe, for introducing this amendment in his normal calm and measured way. Importantly, he has given us all the chance to ask the most basic question of the Bill: where is the plan? It is pleasing that the Minister and the Government have been in listening mode, particularly regarding the Health Services Safety Investigations Body and Healthwatch. I hope that during Committee the Government will continue to listen and make other important changes to the Bill.

At Second Reading, I said the Bill was a power grab. The Nuffield Trust’s October briefing for this Committee puts it more politely. It describes new powers for the Secretary of State as being well beyond those that NHS England holds, which it says enables “more political control” and limits real devolution. The Government are entitled to decide whether they want NHS England’s functions in the department, under political hands. We on these Benches would caution on that, but the Nuffield Trust accepts that some duplication between the department and NHS England is real; the Minister must specify exactly what that duplication is. But if that is the aim, it has to be planned and costed.

I would also caution the noble Lord, Lord Hunt of Kings Heath, and the noble Baroness, Lady Harding, for suggesting that putting NHS England’s functions in the department will bring accountability to the Secretary of State. When we get to Clause 11, we may see that the accountability is missing but the powers are about to be transferred.

Noble Lords will know the architect’s maxim that form follows function, but not here—

Lord Hunt of Kings Heath Portrait Lord Hunt of Kings Heath (Lab)
- Hansard - - - Excerpts

Is the point not that at the moment, parliamentarians can raise issues with Ministers only to be told that something is the responsibility of NHS England? I accept what the noble Lord says about how this is going to work but, ultimately, now the finger is absolutely pointed at Ministers for everything that happens.

Lord Scriven Portrait Lord Scriven (LD)
- Hansard - -

When we get to Clause 11, the noble Lord, Lord Hunt, will see that some of the powers that the Secretary of State now takes, beyond NHS England, will not come before this Parliament. They will just be at the signature of the Secretary of State’s pen.

In this Bill, form comes first and function will follow in due course. We have the demolition notice but are still to see the drawings of the new structure. Let me say how far behind the Government are. The Nuffield Trust, working with the Institute for Government, compared past public sector reforms and NHS abolitions. It found that the key factors for success are not in place here. The abolition was announced without plans to explain its goals to staff and without redundancy funding, which led to months of delay. Detailed planning for the new department began only in early 2026, almost a year after the announcement. Nuffield’s verdict is that the process has been “poorly handled”.

We are still short of very basic information. At Second Reading and in this Committee, the noble Lord, Lord Stevens, who I admit must know something about running the NHS, pointed out that the costs and benefits in the impact assessment are still marked as “not available”. There are also still a number of questions about the timing of when this reform will come in. We have the Government’s estimates that redundancy exits—across the department and NHS England, ICBs and the commissioning support units—will cost between £1 billion and £1.3 billion, to be met from existing allocations, but we must ask which allocations. Which services pay?

Then there is the timetable. On 15 October the Health Service Journal reported that abolition will have to be formally delayed beyond April 2027 unless decisions on future national structures are made within days. Have those decisions been made? Are staff now aware of where they will be transferred? The new operating model has been waiting for ministerial sign-off for months. Ministers are still weighing whether thousands of staff will go to the department or potentially, as we read, into a new stand-alone agency. This Bill sends nearly every function of NHS England to the Secretary of State, yet the Government have not decided where the people who will perform those functions will sit. The department says that it continues to plan for 1 April 2027, but planning a date is not the same as being able to meet it.

The planned 50% job cuts in the department appear to require moving the large majority of central policy and analytical staff. Or is it about cutting operational staff? As the noble Lord, Lord Crisp, said, we need clarity about which staff and which functions will be in the department. It is not clear that the figure is rested on rigorous assessment of who is needed and why. History tells us how this ends: after previous reforms that moved managers from commissioning bodies, the department consultancy spend peaked at over £600 million a year and the number of managers within five years was higher than going into the reorganisation. I fear that this will be another case of “cut first, rehire later and call it efficiency”.

As the noble Earl, Lord Howe, has said, we need not simply rely on the words of noble Lords in this debate. The Darzi review, commissioned by the Government and updated in May, concluded that a top-down reorganisation of NHS England and ICBs is “neither necessary nor desirable” and added:

“Constant reorganisations are costly and distracting”.


We have had six statutory major reorganisations in 30 years, none with clear evidence that the restructure has brought about improvement. The Government commissioned that review; they should read it and learn from it.

I have six questions for the Minister. When will the target operating model be published, and will that be before Report? Is the latest thinking to put transferred NHS England functions and staff into the department, or will the Government set up a stand-alone body? Will the Government publish a full, costed impact assessment, including benefits, and explain where the £1 billion to £1.3 billion comes from? What are the expected costs of disruption, and how will any further delay be limited? Are the Government confident that the 50% cut will not drive up consultancy spending by the end of this Parliament? If the Government do not accept the amendment from the noble Earl, Lord Howe, will they commit to laying a transition plan before Parliament and before Report? In substance, that is what this amendment is asking for.

We on these Benches are not defenders of the status quo. I started in the NHS in the early 1990s and lived through more reorganisations than I care to count. Every one promised less bureaucracy and a freeing up of the front line; none delivered it. If the Government want to put NHS operational matters into political hands, that is their choice, but they owe this House a plan and then a price and then a Bill, in that order. At present we have a Bill and we are still waiting for the other two. I look forward to the Minister’s reply.

Baroness Merron Portrait Baroness Merron (Lab)
- View Speech - Hansard - - - Excerpts

My Lords, I am most grateful to the noble Earl, Lord Howe, for moving this amendment, and to the noble Lord, Lord Kamall, for tabling it. As other noble Lords have observed, it is comprehensive and thorough. It makes the point, which a number of noble Lords have made, about the importance of ensuring that the right processes and assessments are undertaken as we move towards the abolition of NHS England—one of the key things in the Bill. As we are at the beginning of our deliberations, I say to noble Lords that I listen, and have listened, very carefully to the points that are made. I will endeavour to answer a number of points, but I will take some away and write to noble Lords. As ever—and as noble Lords will recall from previous Bills—those letters will be available to all Peers, because I want to do justice to those points.

--- Later in debate ---
I am most grateful to noble Lords who have engaged with me, through round tables and directly, and who have received the correspondence that I sent. I will be glad to continue to do that as we go through Committee and beyond. I reassure noble Lords that we remain committed to parliamentary scrutiny throughout the transition, and we will continue to publish updates as we move forward.
Lord Scriven Portrait Lord Scriven (LD)
- Hansard - -

I asked one specific question, which the Minister may not be able to answer at this moment, but perhaps she could put it in writing. As the Minister has just pointed out to the noble Lord, Lord Stevens, is it the Government’s intention to transfer all the staff into the department or is a stand-alone body being looked at as a potential route for those staff?

Baroness Merron Portrait Baroness Merron (Lab)
- Hansard - - - Excerpts

The intention is the former, but I will gladly write further to the noble Lord on this point.

--- Later in debate ---
Lord Lansley Portrait Lord Lansley (Con)
- View Speech - Hansard - - - Excerpts

My Lords, I want to speak briefly in support of Amendment 211, in the names of the noble Lord, Lord Hunt of Kings Heath, and the noble Baroness, Lady Finlay.

I declare an interest in that I am an officer of the All-Party Parliamentary Group on Access to Medicines and Medical Devices, which has held meetings on the value-based procurement of medical devices. I chair a group looking at breakthrough implantable devices, which has taken an interest in the procurement of just the kinds of devices that the noble Baroness, Lady Finlay, was talking about and in the importance of clinical input to understanding the potential value of such innovative devices.

Some Members of the Committee will know that I have been an advocate of value-based procurement and, where medicine is concerned, value-based pricing as an approach in the National Health Service. There is some good work being done in the department on promoting value-based procurement; we just need to make sure that it is understood and implemented correctly. I have been worried by evidence from some early tenders that the attitude is that the assessment of value should be conditional upon the achievement of a pricing threshold. Sometimes the pricing threshold is set at a point where the calculation of potential value is effectively nullified. If we are serious about understanding value-based pricing, we cannot put in a pricing threshold. You may well attach greater or lesser weight to the pricing element, but you cannot attach a threshold and believe that you are implementing value-based pricing. Quite often, part of the value assessment is to look at issues of patient experience, the outcomes that are to be achieved, the long-term life of a product and how it is used, to arrive at the overall value of a product. This is perfectly normal in commercial procurement. I do not think we are talking about something that should be regarded as exceptional to the NHS. It should be something that is regarded as normal and best practice in procurement.

It is slightly dispiriting in a sense, as I have seen an awful lot of progress on procurement in the NHS. Some 30 years ago, I was working with Unipart—before I came into Parliament—in trying to encourage the NHS, for example, to have just-in-time delivery and barcode-based procurement. That was an awfully long time ago and we have progressed a long way. It seems to me that, if we are keeping pace with the best procurement practices —and I hope the NHS will do that—we should be looking at a value-based system. I very much support what the noble Lord, Lord Hunt, said about that.

Lord Scriven Portrait Lord Scriven (LD)
- View Speech - Hansard - -

My Lords, I speak for these Benches on this short but important group. I thank the noble Earl, Lord Howe, for the amendment on Supply Chain Coordination Ltd and the noble Lord, Lord Hunt of Kings Heath, for his important amendment on value-based procurement.

These amendments may look technical, but they go to something that matters in every clinic and every operating theatre: how the NHS buys what it needs and who is accountable when things go wrong. NHS Supply Chain manages an estimated £8 billion a year of NHS spending on products, and, since 2022, it has carried out the department’s PPE programme. Yet under Clause 2, its shares can be moved by a transfer scheme at the Secretary of State’s discretion. There is no requirement to tell Parliament where they are going, who will exercise the shareholder role, or how continuity of supply will be protected.

Asking for a plan first seems modest. If the pandemic taught us anything, as the noble Lord, Lord Hunt, suggested, it is that supply chain resilience is first and foremost a patient safety issue.

However, a report is not a safeguard in itself. The real risk is that the transfer happens in the middle of a reorganisation, cutting the central headcount by half. The very people who understand how the company works may be gone before the scheme is made. The National Audit Office found that Supply Chain Coordination Ltd was meeting only seven of its 18 key performance indicators and that trusts spend more than £3 billion outside it. A company with that record needs careful handling, not a transfer done in a rush.

On value-based procurement, we welcome the direction of travel. As the noble Lord, Lord Lansley, just pointed out, this is not novel. We do not even have to take his experience of Unipart as an example. We can look at value-based procurement elsewhere: in Denmark, Canada, Italy and even Indonesia. There are models which the Government could use to look at how it is done.

The national guidance published in June is a genuine step forward, asking what delivers the best outcome across the whole patient pathway, rather than simply what the cheapest price is. But with NHS financial pressures, the temptation will always be to grab the lowest price today, without the skills, the capacity, and a finance regime that rewards long-term value. So I ask the Minister: what thinking is being done, not just for the pilots but as part of the new powers that the Secretary of State will have from the transfer of NHS England, on rewarding long-term value in the financial regime? What changes, if any, will the Government make to the financial regime?

There is a wider point that both amendments expose. NHS procurement still sits apart from the rest of the public sector. When the Procurement Bill passed through this House, my noble friend Lady Brinton, with support from all sides, including from the noble Lord, Lord Hunt, asked why the NHS should be treated differently. She warned that the NHS arrangements were not visible and that they were

“SIs at the discretion of any Secretary of State for Health”.—[Official Report, 28/11/22; col. 1578.]

Today, we have one regime for healthcare services and another for goods. NHS buyers are told to take legal advice on how the new value guidance fits both. With NHS England abolished, all that discretion will sit with the Secretary of State, and my noble friend’s warning has become even more relevant.

Therefore, I ask the Minister four simple questions. First, where will the shares in Supply Chain Coordination Ltd go, and when, and will Parliament see the plan before the transfer is made? Secondly, what independent assurance has been commissioned on the continuity of supply during the transition? Thirdly, after NHS England’s abolition, who will own value-based procurement and make sure that it is built into national service frameworks? Fourthly and finally, will the Government now review whether two separate procurement regimes for NHS services and goods still make sense, or will they at least publish how the boundaries between them will be policed, once the Secretary of State holds the pen on both? These are modest amendments, asking for sensible things, and I hope the Minister can give the Committee reassurance.

Baroness Merron Portrait Baroness Merron (Lab)
- View Speech - Hansard - - - Excerpts

My Lords, I most grateful to noble Lords for their observations and the way they have dealt with this. At the outset, I pick up the point that my noble friend Lord Hunt started with and others, including the noble Baroness, Lady Finlay, developed further. We are particularly concerned with personal products and products that need to be personalised. The illustrations that noble Lords have given have been most helpful. The reason for the changes is to see more of that.

NHS: Agency Medical Staff

Lord Scriven Excerpts
Wednesday 9th September 2026

(2 months, 1 week ago)

Lords Chamber
Read Full debate Read Hansard Text Watch Debate Read Debate Ministerial Extracts
Baroness Merron Portrait Baroness Merron (Lab)
- View Speech - Hansard - - - Excerpts

Agency staff can cost the NHS more, which the noble Lord referred to. That is why we now have the agency price cap, which did not exist when agency spending rose completely out of control—for example, it stood at around £3.7 billion in 2015-16, because there were limited national controls. The agency price cap is the maximum amount that an NHS trust would normally pay for an agency worker. I do not quite recognise the situation that the noble Lord referred to on NHS staff, but I will take it away and check the situation.

Lord Scriven Portrait Lord Scriven (LD)
- View Speech - Hansard - -

My Lords, while the Minister talks about reduced agency spending, which is welcome, total temporary workforce costs remain largely unchanged, seemingly displacing into bank premiums, overtime and other insourcing. Will the Minister commit to publishing the total combined costs of flexible staffing, so that Parliament can judge whether taxpayers’ money is actually being saved or merely reshuffled within budget lines?

Baroness Merron Portrait Baroness Merron (Lab)
- View Speech - Hansard - - - Excerpts

I will certainly take away the points that the noble Lord raised, but I do not recognise his description of reshuffling, not least because the requirements on local health providers to reduce agency expenditure are quite clear. They have to report against them and drive further reductions. Those moneys are directed into front-line care. After all, that is what we all want to see.

People with Learning Disabilities: Acute Illness

Lord Scriven Excerpts
Monday 20th July 2026

(3 months, 4 weeks ago)

Lords Chamber
Read Full debate Read Hansard Text Watch Debate Read Debate Ministerial Extracts
Asked by
Lord Scriven Portrait Lord Scriven
- Hansard - -

To ask His Majesty’s Government what assessment they have made of the recommendations in the National Confidential Enquiry into Patient Outcome and Death report Acute illness in people with a learning disability, published on 11 June; and whether they intend to ensure those recommendations are implemented by NHS Trusts.

Baroness Merron Portrait The Parliamentary Under-Secretary of State, Department of Health and Social Care (Baroness Merron) (Lab)
- View Speech - Hansard - - - Excerpts

My Lords, we welcome the National Confidential Enquiry into Patient Outcome and Death’s report and its recommendations. NHS England has circulated learning from the report across the health and care system for regional teams to share it with integrated care boards. NHS accountability arrangements are in place, and immediate improvement actions are under way, including the reasonable adjustment digital flag. The Government are committed to high-quality care for people with a learning disability.

Lord Scriven Portrait Lord Scriven (LD)
- View Speech - Hansard - -

My Lords, enough is enough. Currently, with everything in place, people living with a learning disability still die on average 20 years earlier than their non-learning disabled peers. The key missing part of the jigsaw is a statutory independent review of every such death, legally compelling NHS trusts and other providers to implement the improvements identified. Why are this Government content to rely on the toothless, non-statutory reviews that have changed nearly nothing, and allow this 20-year life expectancy gap to continue?

Baroness Merron Portrait Baroness Merron (Lab)
- View Speech - Hansard - - - Excerpts

I certainly accept the point, and I am not quibbling about the number, because 19 years, which is where we are now, is totally unacceptable. In addition, there is the high percentage of avoidable deaths, which I know the noble Lord is very alive to. While I share the view that this is unacceptable, I would not put it all down to reports. I can say that there are strong expectations of ICBs. As I have mentioned, they are kept to account, and we are continually ensuring that the death of every autistic person and those with a learning disability that is notified is reviewed. The new national-level patient dataset will certainly provide what I would call a single point of truth, which has not been there in the past.

--- Later in debate ---
Baroness Merron Portrait Baroness Merron (Lab)
- View Speech - Hansard - - - Excerpts

That is the reason for the accountability measures that I have outlined. I should add that transparency is absolutely key to that. The guidance that we have issued about supporting the identification of people with learning disability is important; we are at that basic level. That is where we have started, but it will push this forward. Further to my answer to the noble Baroness, Lady Finlay, the guidance for acute hospital staff, for example, included standardised mental capacity assessment forms; they were not in place previously. Each ICB is required, via statutory guidance, to have an executive lead on learning disability and autism.

Lord Scriven Portrait Lord Scriven (LD)
- View Speech - Hansard - -

My Lords, every question that has been asked has shown that the system is failing: people are still dying. The key point is that the accountability mechanism is missing or is too diluted to work. Why do the Government allow this system, which kills people early, to continue? What has the Minister not heard in this debate that assures her that the system is working and that it will somehow change for the better? Evidence and history tell us that the system is broken.

Baroness Merron Portrait Baroness Merron (Lab)
- View Speech - Hansard - - - Excerpts

I hope that I have already agreed with the noble Lord and others about the progress that needs to be made in this area. I have certainly not said that it is acceptable—it is far from acceptable—and the questions have been very helpful in identifying that. The learning disability improvement standards support NHS trusts to measure the quality of care that they provide. All the areas that I have suggested and more are taking us forward. I gave the commitment —and I mean it—to keep these things under review and to seek to improve wherever we can. We look forward to working with the noble Lord in doing so.

Pharmacy Closures

Lord Scriven Excerpts
Wednesday 1st July 2026

(4 months, 2 weeks ago)

Lords Chamber
Read Full debate Read Hansard Text Watch Debate Read Debate Ministerial Extracts
Baroness Merron Portrait Baroness Merron (Lab)
- View Speech - Hansard - - - Excerpts

That comes into the category of underserved areas, particularly if there are fewer pharmacies. I disagree with my noble friend about the overall picture in terms of pharmacies; we are supporting them to do more work, and a bigger range of work strengthens their position. It is not necessary to live right near a pharmacy, because of provision by online pharmacies. Finally, I repeat that local authorities can also seek to open pharmacies where there are underserved areas.

Lord Scriven Portrait Lord Scriven (LD)
- View Speech - Hansard - -

My Lords, community pharmacy has lost thousands of full-time pharmacists in recent years, and many have been recruited directly to other parts of the NHS that can afford to pay more. What more can the Government do to support community pharmacists to minimise this internal displacement and help keep vital local pharmacies open?

Baroness Merron Portrait Baroness Merron (Lab)
- View Speech - Hansard - - - Excerpts

This is an important point and why the refreshed 10-year workforce plan, which we will soon see, will deliver the transformation of the health service, which pharmacists are very much part of. We are also looking to support employers in offering a range of national training opportunities for pharmacists and pharmacy technicians. We need to train and upskill the current workforce, and invest in community pharmacy staff. Pharmacists are very important, but there is a whole team with them. Training will include independent prescriber training, clinical examination skills and training the next generation of education supervisors.